Hair treatment compositions, methods, and kits for treating hair

Information

  • Patent Grant
  • 11975092
  • Patent Number
    11,975,092
  • Date Filed
    Monday, August 16, 2021
    2 years ago
  • Date Issued
    Tuesday, May 7, 2024
    23 days ago
Abstract
The instant disclosure relates to hair treatment compositions that include a unique combination of components that function to impart desirable cosmetic properties to the hair. The hair treatment compositions typically include: at least 0.5 wt. % of at least one non-polymeric mono, di, or tricarboxylic acid, and/or a salt thereof;one or more amines selected from the group consisting of diamines, polyamines, alkylamines, alkanolamines, and a mixture thereof;one or more fructan polysaccharides;one or more prosolvents; andwater.
Description
FIELD OF THE DISCLOSURE

The instant disclosure relates to hair treatment compositions that are particularly useful for improving the quality of hair. Also disclosed are kits that include the hair treatment compositions and methods for using the hair treatment compositions.


BACKGROUND

Many consumers desire to use cosmetic and care compositions that enhance the appearance of keratinous substrates such as hair, e.g., by changing the color, style, and/or shape of the hair, and/or by imparting various cosmetic properties to hair, such as shine and conditioning. Many of the known compositions and processes for enhancing the appearance of hair involve chemical treatments to the hair.


The process of changing the color of hair, for example, can involve depositing an artificial color onto the hair which provides a different shade or color to the hair, and/or lifting the color of the hair, such as lightening the color of dark hair to lighter shades. The process of lifting the color of hair, also known as lightening (or bleaching), generally requires the use of oxidizing agents. Lightening of hair is typically evaluated by the variation in tone height before and after the application of a hair color-altering composition onto hair. This variation corresponds to the degree or level of lightening or lift. The notion of “tone” is based on the classification of the natural shades, one tone separating each shade from the shade immediately following or preceding it, which is well known to hairstyling professionals. The tone heights or levels can range from 1 (black) to 10 (light blond), one unit corresponding to one tone; thus, the higher the number, the lighter the shade or the greater the degree of lift.


Additionally, there are many techniques and compositions for styling or altering the shape of hair. For example, hair care products referred to as “hair relaxers” or “hair straighteners” can relax or straighten curly or kinky hair, including wavy hair. Straightening or relaxing the curls of very curly hair may increase the manageability and ease of styling of such hair. Compositions for permanent waving the hair will impart a curl or a wave to otherwise straight hair. Different types of compositions can be applied onto hair in order to change its shape and make it more manageable, such as alkaline and acidic compositions. Hair relaxers, straighteners, perms, and/or waves may either be applied in a hair salon by a professional or in the home by the individual consumer.


While dyeing or color lifting compositions can effectively alter the color of hair, and relaxing, straightening, perming, and waving compositions can effectively alter the shape of the hair, these chemical treatments can damage the hair fibers and/or irritate the scalp. Thus, in order to reduce or avoid damage to hair, as well as to improve the cosmetic performance of the compositions, the use of new and additional components and novel combinations of ingredients are continuously sought.


However, the choice of components or combinations of ingredients could pose difficulties insofar as they cannot be detrimental to other cosmetic attributes such as ease and uniformity of application, rheology or viscosity properties and stability of the compositions, color deposit and target shade formation, and/or result into more disadvantages such as increased damage or a less healthy look to the hair. It would therefore be desirable to provide the consumer with compositions and methods that can chemically treat the hair while providing other cosmetic advantages such as shine, conditioning, fiber strength, and/or a healthy appearance to the hair, but avoiding or minimizing damage to the hair.


Further, both natural and sensitized or chemically treated hair can contain several kinds of negatively charged moieties, for example, carboxylates (resulting from the hydrolysis of amino acids and thioester bonds) and/or sulfonates (resulting from the oxidation of disulfide bonds). These negatively charged moieties can degrade the cosmetic properties of the hair. Moreover, when hair is chemically treated or damaged, the disulfide bonds in hair (disulfide linkages between two cysteine units) can be reduced or broken, resulting in the formation of thiol groups and/or cysteic acid. There is therefore an ongoing need for hair treatment compositions which help to improve the properties of hair.


SUMMARY OF THE DISCLOSURE

One aspect of the invention pertains to a hair treatment composition comprising:

    • at least 0.5 wt. % of at least one non-polymeric mono, di, or tricarboxylic acid, and/or a salt thereof;
    • one or more amines selected from the group consisting of diamines, polyamines, alkylamines, alkanolamines, and a mixture thereof;
    • one or more fructan polysaccharides;
    • one or more prosolvents; and
    • water.


      In one or more embodiments, the at least one non-polymeric mono, di, or tricarboxylic acid, and/or a salt thereof, is a dicarboxylic acid and/or a salt thereof. In some embodiments, wherein the composition comprises at least one dicarboxylic acid and/or a salt thereof, and the at least one dicarboxylic acid and/or a salt thereof is selected from the group consisting of oxalic acid, malonic acid, malic acid, glutaric acid, citraconic acid, succinic acid, adipic acid, tartaric acid, fumaric acid, maleic acid, sebacic acid, azelaic acid, dodecanedioic acid, phthalic acid, isophthalic acid, terephthalic acid, 2,6-naphthalene dicarboxylic acid, and a salt thereof. In one or more embodiments, the at least one dicarboxylic acid and/or a salt thereof is maleic acid, malonic acid, and/or a salt thereof. In some embodiments, the composition comprises at least one tricarboxylic acid and/or a salt thereof, and the at least one tricarboxylic acid and/or a salt thereof is selected from the group consisting of citric acid, isocitric acid, aconitric acid, propane-1,2,3-tricarboxylic acid, benzene-1,3,5-tricarboxylic acid, and a thereof. In one or more embodiments, the at least one tricarboxylic acid and/or a salt thereof is citric acid, and/or a salt thereof. In some embodiments, the composition comprises at least 0.5 to about 20 wt. % of at least one non-polymeric mono, di, or tricarboxylic acid and/or a salt thereof, based on the total weight of the hair treatment composition. In one or more embodiments, the composition comprises one or more alkylamines and/or alkanolamines selected from the group consisting of compounds of formula (II):

      NR3R4R5  (II)

      wherein R3, R4 and R5 are independently H, C1-C40 alkyl, C1-C40 monohydroxyalkyl or C2-C40 polyhydroxyalkyl, provided that at least one of R3, R4 and R5 is an alkyl or mono or polyhydroxyalkyl. In some embodiments, the composition comprises one or more alkanolamines selected from the group consisting of monoethanolamine, diethanolamine, triethanolamine, monoisopropanolamine, diisopropanolamine, N-dimethylamino-ethanolamine, 2-amino-2-methyl-1-propanol, triisopropanolamine, 2-amino-2-methyl-1,3-propanediol, 3-amino-1,2-propanediol, 3-dimethylamino-1,2-propanediol, tris(hydroxymethylamino)methane, and a mixture thereof. In one or more embodiments, the composition comprises monoethanolamine. In some embodiments, the total amount of the one or more amines is about 1 to about 20 wt. %, based on the total weight of the hair treatment composition. In one or more embodiments, the one or more fructan polysaccharides are inulin polysaccharides and/or levan polysaccharides. In some embodiments, the one or more fructan polysaccharides comprises inulin. In some embodiments, the one or more fructan polysaccharides are present in an amount from about 1 to about 5 wt. %, based on the total weight of the hair treatment composition. In one or more embodiments, the one or more prosolvents is selected from the group consisting of hexylene glycol, butylene glycol, propylene glycol, and combinations thereof.


Any of the above embodiments may be combined. For example, in some embodiments, the hair treatment composition comprises:

    • about 2 to about 4 wt. % of maleic acid and/or a salt thereof;
    • about 1 to about 3 wt. % of ethanolamine;
    • about 1 to about 5 wt. % inulin;
    • about 2 to about 4 wt. % of a mixture of hexylene glycol and butylene glycol; and
    • water.


Another aspect of the invention pertains to methods of treating hair. In some embodiments, the method comprises applying any of the compositions described herein to hair. In one or more embodiments, the composition is applied to hair as part of a shampoo or conditioning routine. In some embodiments, the composition is applied after a chemical relaxer is applied to the hair.







DETAILED DESCRIPTION OF THE DISCLOSURE

The term “hair treatment composition” encompasses many types of compositions for application to the hair, for example, chemical relaxer compositions, shampoos, conditioners, hair-rinses, hair lotions, hair gels, mouse-type products, sprays, etc. A hair treatment composition is characterized by its ability to provide a cosmetic benefit to the hair. As is well-known, a shampoo provides cleansing benefits to the hair, a conditioner provides conditioning benefits to the hair, and gels can provide styling benefits to the hair. Non-limiting examples of additional benefits that can be imparted to hair include strength, smoothness, softness, and suppleness.


The hair treatment compositions of the instant disclosure typically include:

    • at least 0.5 wt. % of at least one non-polymeric mono, di, or tricarboxylic acid, and/or a salt thereof;
    • one or more amines selected from the group consisting of diamines, polyamines, alkylamines, alkanolamines, and a mixture thereof;
    • one or more fructan polysaccharides;
    • one or more prosolvents; and
    • water.


The above compositions, which feature a unique combinations of ingredients, advantageously provide hair strengthening benefits together with styling benefits.


The hair treatment compositions described herein may be in any suitable physical form. Suitable forms include, but are not limited to low to moderate viscosity liquids, lotions, milks, mousses, sprays, gels, creams, pastes, clays, bars, conditioners, and the like. For instance, spray formulations may be dispensed from containers that include aerosol dispensers or pump spray dispensers. Such dispensers are known in the art and are commercially available from a variety of manufacturers. When the spray formulation is dispensed from a pressurized aerosol container, a propellant may be used to force the composition out of the container. Suitable propellants include, but are not limited to, a liquefiable gas or a halogenated propellant. Examples of suitable propellants include dimethyl ether and hydrocarbon propellants such as propane, n-butane, iso-butane, CFCs, and CFC-replacement propellants. The propellants may be used singly or admixed. Furthermore, the leave-on hair styling compositions may be in the form of an emulsion (e.g., water-in-oil or oil-in-water emulsion). In some cases, the leave-in hair styling composition is in the form of a paste, which may be a semi-solid product that can be applied throughout the hair using one's fingers.


The hair treatment compositions may be packaged in a variety of different containers, such as, for example, a ready-to-use container. Non-limiting examples of useful packaging include tubes, jars, caps, unit dose packages, and bottles, including squeezable tubes and bottles.


Non-Polymeric Mono, Di, Or Tricarboxylic Acid


A non-polymeric mono, di, and/or tricarboxylic acid is an organic compound having one (mono), two (di), or three (tri) carboxylic acid groups (—COOH). The non-polymeric mono, di, and tricarboxylic acids, and/or salts thereof, typically have a molecular weight of less than about 500 g/mol, less than about 400 g/mol, or less than about 300 g/mol.


Non-limiting examples of monocarboxylic acids, or salts thereof, include formic acid, acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, entanthic acid, caprylic acid, pelargonic acid, capric acid, undecylic acid, lauric acid, tridecylic acid, lauric acid, tridecylic acid, myristic acid, pentadecylic acid, palmitic acid, margaric acid, stearic acid, nonadecylic acid, arachidic acid, lactic acid, a salt thereof, and a mixture thereof. In some cases, the hair treatment compositions include at least lactic acid and/or a salt thereof.


Non-limiting examples of dicarboxylic acids and/or salts thereof include oxalic acid, malonic acid, malic acid, glutaric acid, citraconic acid, succinic acid, adipic acid, tartaric acid, fumaric acid, maleic acid, sebacic acid, azelaic acid, dodecanedioic acid, phthalic acid, isophthalic acid, terephthalic acid, 2,6-naphthalene dicarboxylic acid, a salt thereof, and a mixture thereof. In some cases, the hair treatment compositions include oxalic acid, malonic acid, malic acid, maleic acid, a salt thereof, or a mixture thereof.


Non-limiting examples of tricarboxylic acids and salts thereof include citric acid, isocitric acid, aconitric acid, propane-1,2,3-tricarboxylic acid, benzene-1,3,5-tricarboxylic acid, a salt thereof, and a mixture thereof. In some instances, the hair treatment compositions include at least citric acid and/or a salt thereof.


In some cases, the hair treatment compositions include at least one or more dicaboxylic acids, and/or a salt thereof, in particular, oxalic acid, malonic acid, malic acid, maleic acid, a salt thereof, or a mixture thereof. A particularly useful dicarboxylic acid is malonic acid and/or a salt thereof.


The total amount of the at least one non-polymeric mono, di, or tricarboxylic acid, and/or a salt thereof, is at least 0.5 wt. %, based on the total weight of the hair treatment composition. In some cases, the total amount of the at least one non-polymeric mono, di, or tricarboxylic acid, and/or salt thereof, is at least 0.6, 0.7, 0.8, 0.9, or 1 wt. % up to about 15, 20, 25, or 30 wt. %. Furthermore, the total amount of the at least one non-polymeric mono, di, or tricarboxylic acid, and/or salt thereof, may be at least 0.5 wt. % to about 50 wt. %, at least 0.5 wt. % to about 40 wt. %, at least 0.5 wt. % to about 30 wt. %, at least 0.5 wt. % to about 20 wt. %, at least 0.5 wt. % to about 10 wt. %, at least 0.5 wt. % to about 5 wt. %, at least 0.8 wt. % to about 50 wt. %, at least 0.8 wt. % to about 40 wt. %, at least 0.8 wt. % to about 30 wt. %, about 0.8 to about 20 wt. %, about 0.8 to about 10 wt. %, about 0.8 wt. % to about 5 wt. %, about 1 wt. % to about 50 wt. %, about wt. % to about 40 wt. %, about 1 wt. % to about 30 wt. %, about 1 wt. % to about 20 wt. %, about 1 wt. % to about 10 wt. %, about 1 wt. % to about 5 wt. %, about 2 wt. % to about 50 wt. %, about 2 wt. % to about 40 wt. %, about 2 wt. % to about 30 wt. %, about 2 wt. % to about 20 wt. %, about 2 wt. % to about 10 wt. %, or about 2 wt. % to about 5 wt. %.


Amines


Non-limiting examples of the types of amines that may be used in the hair treatment compositions are vast, but may include diamines, polyamines, alkylamines, alkanolamines, and mixtures thereof. The one or more amines may be primary, secondary, tertiary amines, and mixtures thereof.


Diamines


Non-limiting examples of diamines that may be useful may be primary amines and secondary amines. The diamine can include both primary and secondary amine groups. Optional diamines may include at least one ethylene oxide group. For example, between 1 and 4 ethylene oxide groups can be present in the diamine. The diamine may optionally include propylene oxide groups. For example, between 1 and 4 propylene oxide groups can be present in the diamine. Non-limiting examples of diamines include 4,9-dioxadodecane-diamine; 4,7,10-trioxa-1,13-tridecanediamine; ethylenediamino; polyoxypropylene diamine; polyethylene glycol diamine; triethylene glycol diamine (2OE); n-(2-hydroxyethyl)-ethylenediamine; 1,3-diaminopropane; 1,7-diaminoheptane; 1,4-diaminobutane; 1,2-diaminopropane; 1,6-diaminohexane; 1,11-diamino-3,6,9-trioxaundecane; 1,5-diaminopentane; polyoxyethylene diamine; 2,2-dimethyl-1,3-propanediamine; 2,2-bis(aminoethoxy)propane; 4,7,10-trioxa-1,13-tridecanediamine; 1,3-diaminopentane; 4,7,10-trioxa-1,13; 1,5-diamino-2-methylpentane; (3s,4s)-(−)-3,4-hexanediamine dihydrochloride; 1,9-diaminononane, and mixtures thereof.


In some cases, diamines may be selected from the group consisting of 4,9-dioxadodecane-diamine, 4,7,10-trioxa-1,13-tridecanediamine, ethylenediamino, polyoxypropylene diamine, polyethylene glycol diamine, triethylene glycol diamine (2OE); n-(2-hydroxyethyl)-ethylenediamine; 1,3-diaminopropane, 1,7-diaminoheptane, 1,4-diaminobutane, 1,2-diaminopropane, 1,6-diaminohexane, 1,11-diamino-3,6,9-trioxaundecane, 1,5-diaminopentane, polyoxyethylene diamine, 2,2-dimethyl-1,3-propanediamine, 2,2-bis(aminoethoxy)propane, 4,7,10-trioxa-1,13-tridecanediamine, 1,3-diaminopentane, 4,7,10-trioxa-1,13; 1,5-diamino-2-methylpentane, (3s,4s)-(−)-3,4-hexanediamine dihydrochloride, 1,9-diaminononane, and mixtures thereof.


Polyamines


Polyamines have more than two amino groups. In some cases, the composition of the instant disclosure may include one or more polyamines, but in some cases, the compositions are free or essentially free of polyamines. The polyamine may be, for example, aminated polysaccharides comprising multiple amino groups, such as, for example, hydrolysates of aminated polysaccharides.


The polyamine may also be a polymer comprising multiple amino groups including homopolymers, copolymers, and terpolymers.


In some cases, polyamines are chosen from polyethyleneimines. Polyethyleneimines may optionally be substituted. Non-limiting examples of polyethyleneimines which may be used include LUPASOL products commercially available from BASF. Suitable examples of LUPASOL polyethyleneimines include LUPASOL PS, LUPASOL PL, LUPASOL PR8515, LUPASOL G20, LUPASOL G35 as well as LUPASOL SC Polythyleneimine Reaction Products (such as LUPASOL SC-61B, LUPASOL SC-62J, and LUPASOL SC-86X). Other non-limiting examples of polyethyleneimines which may be used in the composition according to the present invention are the EPOMIN products commercially available from Aceto. Suitable examples of EPOMIN polyethyleneimines include EPOMIN SP-006, EPOMIN SP-012, EPOMIN SP-018, and EPOMIN P-1000. Suitable polyamines s also be chosen from polyvinylamines. Examples thereof include LUPAMINES 9095, 9030, 9010, 5095, 1595 from BASF.


The polyamine compounds can also be substituted. An example of such a compound is PEG-15 Cocopolyamine from Cognis.


In some cases, the polyamine is chosen from proteins and protein derivatives. Non-limiting examples of suitable proteins and protein derivatives f include those listed at pages 1701 to 1703 of the C.T.F.A. International Cosmetic Ingredient Dictionary and Handbook, 8th edition, vol. 2, (2000), which is incorporated herein by reference in its entirety. In some cases, the at least one polyamine is chosen from wheat protein, soy protein, oat protein, collagen, and keratin protein.


The polyamine may be an alkoxylated polyamine. The alkoxylated polyamines may be chosen from amine compounds having at least two amino groups and at least one degree of alkoxylation. The alkoxylation is provided by an alkylene oxide group which may be chosen from ethylene oxide and propylene oxide. Non-limiting examples of suitable alkoxylated polyamines include compounds corresponding to the following formula:

NH2R(R′CHCH2O)x(R′CHCH2O)y(R′CHCH2O)z—RNH2

    • wherein R represents a —CH2-, —CH2CH2—, —CHCH3— or —C(CH3)2— group, or a hydrocarbon radical containing at least 3 carbon atoms that is linear or branched, acyclic or cyclic, saturated or unsaturated, aliphatic or aromatic, substituted or unsubstituted; x, y, and z independently of one another, represent numbers of from 0 to about 100; R′ represents hydrogen, or an alkyl group, preferably a methyl group; and The sum of x+y+z is at least 1. In some cases, R is a linear or branched, acyclic alkyl or alkenyl group or an alkyl phenyl group; x, y, and z independently of one another, preferably represent numbers ranging from 2 to 100.


Non-limiting examples of the alkoxylated polyamines include, for example, tetradecyloxypropyl-1,3-diaminopropane; a C12-14 alkyl oxypropyl-1,3-diaminopropane; a C12-15 alkyloxypropyl amine and other similar materials that are commercially available from Tomah under the tradename of TOMAH DA-17. Other examples of alkoxylated polyamines are diamine compounds belonging to the Jeffamine series such as the JEFFAMINE D and JEFFAMINE ED series available from Huntsman Corporation, Salt Lake City, Utah. Examples of these Jeffamine compounds are JEFFAMINE D230, JEFFAMINE D400, JEFFAMINE D2000, JEFFAMINE D4000, JEFFAMINE HK-511, JEFFAMINE ED600, JEFFAMINE ED900, and JEFFAMINE ED2003. JEFFAMINE D series compounds are amine terminated PPGs (polypropylene glycols) and JEFFAMINE ED series compounds are polyether diamine based with a predominantly PEG (polyethylene glycol) backbone.


Other non-limiting examples of suitable alkoxylated polyamines in the diamine form include compounds corresponding to the following formula:

NH2(CH2)xOCH2CH2O(CH2)xNH2

    • wherein x is 2 or 3.


Examples of alkoxylated polyamines are diamine compounds belonging to the JEFFAMINE series available from Huntsman Corporation, Salt Lake City, Utah, such as JEFFAMINE EDR148, and JEFFAMINE EDR176.


Additional non-limiting examples of alkoxylated polyamines in the triamine form include compounds corresponding to the following formula:




embedded image




    • wherein R is hydrogen, —CH2 or —C2H5, n=0 or 1, and x, y, and z independently of one another, represent numbers of from 0 to 100 and the sum of x+y+z is at least 1.





Examples of alkoxylated polyamines are triamine compounds belonging to the JEFFAMINE series such as the JEFFAMINE T series available from Huntsman Corporation, Salt Lake City, Utah. Examples of the JEFFAMINE T series compounds are JEFFAMINE T403, JEFFAMINE T3000, and JEFFAMINE T5000. JEFFAMINE T series compounds are triamines made by reacting PO with a triol initiator followed by aminating the terminal hydroxyl groups.


Alkylamines and Alkanolamines


The one or more alkylamines and/or one or more alkanolamines that may be included in the compositions include compounds of formula (II):

NR3R4R5  (II)

    • wherein R3, R4 and R5 are independently H, C1-C40 alkyl, C1-C40 monohydroxyalkyl or C2-C40 polyhydroxyalkyl, provided that at least one of R3, R4 and R5 is an alkyl or mono or polyhydroxyalkyl. In some cases, R3, R4 and R5 are independently H, C1-C2 alkyl, C1-C20 monohydroxyalkyl or C2-C20 polyhydroxyalkyl, provided that at least one of R3, R4 and R5 is an alkyl or mono or polyhydroxyalkyl. Finally, R3, R4 and R5 may independently be H, C1-C10 alkyl, C1-C10 monohydroxyalkyl or C2-C10 polyhydroxyalkyl, provided that at least one of R3, R4 and R5 is an alkyl or mono or polyhydroxyalkyl.


Non-limiting examples of alkanolamines include monoethanolamine, diethanolamine, triethanolamine, monoisopropanolamine, diisopropanolamine, N-dimethylamino-ethanolamine, 2-amino-2-methyl-1-propanol, triisopropanolamine, 2-amino-2-methyl-1,3-propanediol, 3-amino-1,2-propanediol, 3-dimethylamino-1,2-propanediol, tris(hydroxymethylamino)methane, and mixtures thereof. In some cases, the compositions include at least monoethanol amine. In some cases, the compositions include at least monoethanolamine.


Further non-limiting examples of alkylamines include aliphatic amine compounds corresponding to the following formula and their salts:

RN(R′)2

    • wherein R is a hydrocarbon radical containing at least 6 carbon atoms. In addition, R can be linear or branched, acyclic or cyclic, saturated or unsaturated, aliphatic or aromatic, substituted or unsubstituted. Typically, R is a linear or branched, acyclic alkyl or alkenyl group or an alkyl phenyl group; and the groups R′, which may be identical or different, represent H or a hydrocarbon radical containing less than 6 carbon atoms. In addition, the groups R′, which may be identical or different, are linear or branched, acyclic or cyclic, saturated or unsaturated, substituted or unsubstituted. In some cases, the groups R′, which may be identical or different, are H or a methyl group.


In some cases, alkylamines include, but are not limited to the following examples: dimethyl lauramine, dimethyl behenamine, dimethyl cocamine, dimethyl myristamine, dimethyl palmitamine, dimethyl stearamine, dimethyl tallowamine, dimethyl soyamine, stearamine, soyamine, cocamine, lauramine, palmitamine, oleamine, tallow amine and mixtures thereof.


Other non-limiting examples of alkyl monoamines include amidoamine compounds corresponding to the following formula and their salts:

RCONHR′N(R″)2

    • wherein: R is a hydrocarbon radical containing at least 6 carbon atoms. In addition, R can be linear or branched, acyclic or cyclic, saturated or unsaturated, aliphatic or aromatic, substituted or unsubstituted. Typically, R is a linear or branched, acyclic alkyl or alkenyl group or an alkyl phenyl group; and R′ is a divalent hydrocarbon radical containing less than 6 carbon atoms, or 2 or 3 carbon atoms, and R″ is H or a hydrocarbon radical containing less than 6 carbon atoms. In addition, R″ is linear or branched, acyclic or cyclic, saturated or unsaturated, substituted or unsubstituted. Typically, R″ is a linear or branched, acyclic alkyl or alkenyl group. In some cases, R″ is H or a methyl group.


Examples of amidoamines that are useful in the compositions of the instant disclosure include, but are not limited to the following: oleamidopropyl dimethylamine, stearamidopropyl dimethylamine, isostearamidopropyl dimethylamine, stearamidoethyl dimethylamine, lauramidopropyl dimethylamine, myristamidopropyl dimethylamine, behenamidopropyl dimethylamine, dilinoleamidopropyl dimethylamine, palmitamidopropyl dimethylamine, ricinoleamindopropyl dimethylamine, soyamidopropyl dimethylamine, wheat germamidopropyl dimethylamine, sunflowerseedamidopropyl dimethylamine, almondamidopropyl dimethylamine, avocadoamidopropyl dimethylamine, babassuamidopropyl dimethylamine, cocamidopropyl dimethylamine, minkamidopropyl dimethylamine, oatamidopropyl dimethylamine, sesamidopropyl dimethylamine, tallamidopropyl dimethylamine, brassicaamidopropyl dimethylamine, olivamidopropyl dimethylamine, palmitamidopropyl dimethylamine, stearamidoethyldiethylamine, and mixtures thereof.


Additional Amines


Additional amines that may be useful include alkoxylated monoamines. The alkoxylated monoamines are compounds having an amino group and at least one degree of alkoxylation. The alkoxylation is provided by an alkylene oxide group which is often chosen from ethylene oxide and propylene oxide.


Non-limiting examples of suitable alkoxylated monoamines include compounds corresponding to the following formula:

RN[(R′CHCH2O)xH][(R′CHCH2O)yH]

    • wherein R is a hydrocarbon radical containing at least 6 carbon atoms. R can be linear or branched, acyclic or cyclic, saturated or unsaturated, aliphatic or aromatic, substituted or unsubstituted; x and y, independently of one another, represent numbers of from 0 to 100 provided that the sum of x+y is >0; the groups R′, which may be identical or different, represent hydrogen, or an alkyl group such as a methyl group. Typically, R is a linear or branched, acyclic alkyl or alkenyl group or an alkyl phenyl group; x and y, independently of one another, are each typically a number from 0 to 30. Typically, one R′ group is hydrogen, and the other one is methyl.


Non-limiting examples of alkoxylated monoamines include PEG-2 Cocamine, PEG-3 Cocamine, PEG-5 Cocamine, PEG-10 Cocamine, PEG-15 Cocamine, PEG-20 Cocamine, PEG-2 Lauramine, PEG-12 Palmitamine, PEG-2 Rapeseedamine, PEG-2 Oleamine, PEG-5 Oleamine, PEG-6 Oleamine, PEG-10 Oleamine, PEG-15 Oleamine, PEG-20 Oleamine, PEG-25 Oleamine, and PEG-30 Oleamine. Other examples are alkoxylated derivatives of soyamine, stearamine and tallow amine.


Other non-limiting examples of suitable alkoxylated monoamines include compounds corresponding the following formula:

RNR″[(R′CHCH2O)xH]

    • wherein R is a hydrocarbon radical containing at least 6 carbon atoms. R can be linear or branched, acyclic or cyclic, saturated or unsaturated, aliphatic or aromatic, substituted or unsubstituted; x represents a number of from 1 to 100; R′ represents hydrogen, or an alkyl group such as in particular a methyl group; and R″ is a hydrogen or a hydrocarbon radical. Typically, R is a linear or branched, acyclic alkyl or alkenyl group or an alkyl phenyl group; x is typically a number from 1 to 30. When R″ is a hydrocarbon radical group, this group may be linear or branched, saturated or unsaturated, substituted or unsubstituted. The hydrocarbon radical represented by R″ may also contain an alkoxylated moiety (as defined by [(R′CHCH2O)yH]), and/or heteroatoms such as nitrogen. When R″ contains at least one alkoxylated moiety, the total number of alkoxylation in the formula may range from 1 to 120. Examples of alkoxylated monoamines include PEG-3 Tallow Aminopropylamine, PEG-10 Tallow Aminopropylamine, PEG-15 Tallow Aminopropylamine, and PEG-105 Behenyl Propylenediamine.


Additional non-limiting examples of alkoxylated monoamines include compounds corresponding to the following formula:

R(R′CHCH2O)x(R′CHCH2O)yNHy

    • wherein R is a hydrocarbon radical containing at least 6 carbon atoms. R can be linear or branched, acyclic or cyclic, saturated or unsaturated, aliphatic or aromatic, substituted or unsubstituted; x and y, independently of one another, represent numbers of from 0 to 100 with the proviso that the sum of x+y is >0; the groups R′, which may be identical or different, represent hydrogen, or an alkyl group such as in particular a methyl group. Typically, R is a linear or branched, acyclic alkyl or alkenyl group or an alkyl phenyl group; x and y, independently of one another, are each typically a number from 0 to 30. Examples of alkoxylated monoamines include polyetheramines containing a monoamine group. These polyetheramines are commercially available from Hunstman under the tradename JEFFAMINE (M series such as M-600, M-1000, M-2005 and M-2070) and SURFONAMINE series (B-60, B-100, B-200, L-100, L-200, L-207, L-300).


The total amount of the one or more amines may vary, but in some cases, the total amount of the one or more amines is about 0.1 to about 50 wt. %, based on the total weight of the hair treatment composition. In some cases, the total amount of the one or more amines is about 0.1 to about 50 wt. %, about 0.1 to about 30 wt. %, about 0.1 to about 25 wt. %, about 0.1 to about 20 wt. %, about 0.1 to about 15 wt. %, about 0.1 to about 10 wt. %, about 0.5 to about 35 wt. %, about 0.5 to about 30 wt. %, about 0.5 to about 25 wt. %, about 0.5 to about 20 wt. %, about 0.5 to about 15 wt. %, about 0.5 to about 10 wt. %, about 1 to about 35 wt. %, about 1 to about 30 wt. %, about 1 to about 25 wt. %, about 1 to about 20 wt. %, about 1 to about 15 wt. %, about 1 to about 10 wt. %, or about 1 to about 5 wt. %.


Fructan Polysaccharides


Fructan polysaccharides (also referred to as just “fructan”) are polymers of fructose molecules. Fructan polysaccharides include inulin polysaccharides (also referred to as just “inulin”) and levan polysaccharide (also referred to as just “levan”). In some instances, the leave-on hair styling compositions include inulin polysaccharides; in some cases the leave-on hair styling compositions include levan polysaccharides; but in some cases the leave-on hair styling compositions may include both inulin and levan polysaccharides.


The total amount of the one or more fructan polysaccharides can vary, but is typically about 0.1 to about 40 wt. %, based on the total weight of the leave-on hair styling composition. The total amount of the one or more fructan polysaccharides may be about 0.1 to about 30 wt. %, about 0.1 to about 20 wt. %, about 0.1 to about 15 wt. %, about 0.1 to about 10 wt. %, about 0.1 to about 5 wt. %, about 1 to about 40 wt. %, about 1 to about 30 wt. %, about 1 to about 20 wt. %, about 1 to about 15 wt. %, about 1 to about 10 wt. %, or about 1 to about 5 wt. %.


Inulin refers to a class of polysaccharides produced by a variety of plants, and is an example of a fructan polysaccharide (also referred to as just “fructan”) are polymers of fructose molecules. Inulin is commonly extracted from chicory root, and may contain (2→1) linked β-d-fructosyl residues (n=2-60), usually with an (1↔2) α-d-glucose end group. The inulin may be present in amounts ranging from about 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.1, 1.2, 1.3, 1.4, or 1.5 to about 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 6, 7, 8, 9 or 10 wt. % by total weight of the composition. In further embodiments, the inulin is present in an amount of from about 0.1 to about 10 wt. %, or about 0.5 to about 2.5 wt. %.


Prosolvent


As used herein “prosolvent” refers to a solvent system which enhances the performance of the composition by enhancing penetration of the active ingredients into the hair. In one or more embodiments, the prosolvent comprises one or more glycol compounds. In further embodiments, the glycol compounds are selected from the group consisting of hexylene glycol, butylene glycol, propylene glycol, and combinations thereof.


In one or more embodiments, the prosolvent comprises a mixture of two ingredients in a ratio ranging from about 1:2 to about 2:1, or more specifically 1:1. In some embodiments, the prosolvent comprises hexylene glycol and butylene glycol. In one or more embodiments, the prosolvent comprises propylene glycol in addition to hexylene glycol and butylene glycol.


While not wishing to be bound to any particular theory, it is thought that the presence of the prosolvent increases the efficacy of penetrating actives such as maleic acid. The prosolvent may also act as a surfactant and assists in stabilizing the emulsion. Emulsion stability is a particularly important effect when low pH ingredients are present (e.g., maleic acid) because such low pH ingredients can have a negative effect on emulsion stability. Thus, it is thought that the prosolvent works to counteract the negative effect of low pH ingredients on emulsion stability as well as assisting active penetration to the cortex.


Other Components


In one or more embodiments, the hair treatment compositions described in may contain one or more additional ingredients. Examples include, but are not limited to surfactants, cationic conditioning agents, silicones, film formers, other polymers, fragrance and preservatives. Additional details regarding such additional ingredients follows below.


Surfactants


Cationic Surfactants


The term “cationic surfactant” means a surfactant that is positively charged when it is contained in the composition according to the disclosure. This surfactant may bear one or more positive permanent charges or may contain one or more functions that are cationizable in the composition according to the disclosure.


Non-limiting examples of cationic surfactants include behenalkonium chloride, benzethonium chloride, cetylpyridinium chloride, behentrimonium chloride, lauralkonium chloride, cetalkonium chloride, cetrimonium bromide, cetrimonium chloride, cethylamine hydrofluoride, chlorallylmethenamine chloride (Quaternium-15), distearyldimonium chloride (Quaternium-5), dodecyl dimethyl ethylbenzyl ammonium chloride(Quaternium-14), Quaternium-22, Quaternium-26, Quaternium-18 hectorite, dimethylaminoethylchloride hydrochloride, cysteine hydrochloride, diethanolammonium POE (10) oletyl ether phosphate, diethanolammonium POE (3)oleyl ether phosphate, tallow alkonium chloride, dimethyl dioctadecylammoniumbentonite, stearalkonium chloride, domiphen bromide, denatonium benzoate, myristalkonium chloride, laurtrimonium chloride, ethylenediamine dihydrochloride, guanidine hydrochloride, pyridoxine HCl, iofetamine hydrochloride, meglumine hydrochloride, methylbenzethonium chloride, myrtrimonium bromide, oleyltrimonium chloride, polyquaternium-1, procainehydrochloride, cocobetaine, stearalkonium bentonite, stearalkoniumhectonite, stearyl trihydroxyethyl propylenediamine dihydrofluoride, tallowtrimonium chloride, and hexadecyltrimethyl ammonium bromide.


Anionic Surfactants


The term “anionic surfactant” means a surfactant comprising, as ionic or ionizable groups, only anionic groups. These anionic groups are chosen preferably from the groups CO2H, CO2, SO3H, SO3, OSO3H, OSO3O2PO2H, O2PO2H and O2PO22-.


The anionic surfactant(s) that may be used may be alkyl sulfates, alkyl ether sulfates, alkylamido ether sulfates, alkylaryl polyether sulfates, monoglyceride sulfates, alkylsulfonates, alkylamide sulfonates, alkylarylsulfonates, alpha-olefin sulfonates, paraffin sulfonates, alkylsulfosuccinates, alkyl ether sulfosuccinates, alkylamide sulfosuccinates, alkyl sulfoacetates, acylsarcosinates, acylglutamates, alkylsulfosuccinamates, acylisethionates and N-acyltaurates, salts of alkyl monoesters and polyglycoside-polycarboxylic acids, acyllactylates, salts of D-galactoside uronic acids, salts of alkyl ether carboxylic acids, salts of alkyl aryl ether carboxylic acids, and salts of alkylamido ether carboxylic acids; or the non-salified forms of all of these compounds, the alkyl and acyl groups of all of these compounds containing from 6 to 24 carbon atoms and the aryl group denoting a phenyl group. Some of these compounds may be oxyethylenated and then preferably comprise from 1 to 50 ethylene oxide units.


The salts of C6-C24 alkyl monoesters of polyglycoside-polycarboxylic acids may be chosen from C6-C24 alkyl polyglycoside-citrates, C6-C24 alkyl polyglycoside-tartrates and C6-C24 alkyl polyglycoside-sulfo succinates.


When the anionic surfactant(s) are in salt form, they may be chosen especially from alkali metal salts such as the sodium or potassium salt and preferably the sodium salt, ammonium salts, amine salts and in particular amino alcohol salts, or alkaline-earth metal salts such as the magnesium salt.


Examples of amino alcohol salts that may especially be mentioned include monoethanolamine, diethanolamine and triethanolamine salts, monoisopropanolamine, diisopropanolamine or triisopropanolamine salts, 2-amino-2-methyl-1-propanol salts, 2-amino-2-methyl-1,3-propanediol salts and tris(hydroxymethyl)aminomethane salts. Alkali metal or alkaline-earth metal salts and in particular the sodium or magnesium salts may be used.


Mention is also made of (C6-C24)alkyl sulfates, (C6-C24)alkyl ether sulfates, which are optionally ethoxylated, comprising from 2 to 50 ethylene oxide units, and mixtures thereof, in particular in the form of alkali metal salts or alkaline-earth metal salts, ammonium salts or amino alcohol salts. In some cases, the anionic surfactant(s) are chosen from (C10-C20)alkyl ether sulfates, and in particular sodium lauryl ether sulfate containing 2.2 mol of ethylene oxide.


Amphoteric Surfactants


Amphoteric surfactants useful in the cosmetic compositions disclosed herein may be chosen from betaines, sultaines, amphoacetates, amphoproprionates, and mixtures thereof. More typically, betaines and amphoproprionates are used, and most typically betaines. Betaines which can be used in the current compositions include those having the formulas below:




embedded image




    • wherein

    • R10 is an alkyl group having 8-18 carbon atoms; and

    • n is an integer from 1 to 3.





Particularly useful betaines include, for example, coco betaine, cocoamidopropyl betaine, lauryl betaine, laurylhydroxy sulfobetaine, lauryldimethyl betaine, cocoamidopropyl hydroxysultaine, behenyl betaine, capryl/capramidopropyl betaine, lauryl hydroxysultaine, stearyl betaine, and mixtures thereof. Typically, the at least one betaine compound is selected from the group consisting of coco betaine, cocoamidopropyl betaine, behenyl betaine, capryl/capramidopropyl betaine, lauryl betaine, and mixtures thereof, and more typically coco betaine.


Hydroxyl sultaines useful in the compositions of the invention include the following




embedded image




    • wherein

    • R is an alkyl group having 8-18 carbon atoms.





Useful alkylamphoacetates include those having the formula




embedded image




    • wherein

    • R is an alkyl group having 8-18 carbon atoms.

    • useful alkyl amphodiacetates include those having the formula







embedded image




    • wherein

    • R is an alkyl group having 8-18 carbon atoms.





The amphoteric surfactants of the present disclosure may be optionally quaternized secondary or tertiary aliphatic amine derivatives, in which the aliphatic group is a linear or branched chain comprising from 8 to 22 carbon atoms, said amine derivatives containing at least one anionic group, for instance a carboxylate, sulfonate, sulfate, phosphate or phosphonate group.


Non-Ionic Surfactants


Nonionic surfactants are compounds well known in themselves (see, e.g., in this regard, “Handbook of Surfactants” by M. R. Porter, Blackie & Son publishers (Glasgow and London), 1991, pp. 116-178), which is incorporated herein by reference in its entirety.


The nonionic surfactant can be, for example, selected from alcohols, alpha-diols, alkylphenols and esters of fatty acids, these compounds being ethoxylated, propoxylated or glycerolated and having at least one fatty chain comprising, for example, from 8 to 18 carbon atoms, it being possible for the number of ethylene oxide or propylene oxide groups to range from 2 to 50, and for the number of glycerol groups to range from 1 to 30. Maltose derivatives may also be mentioned. Non-limiting mention may also be made of copolymers of ethylene oxide and/or of propylene oxide; condensates of ethylene oxide and/or of propylene oxide with fatty alcohols; polyethoxylated fatty amides comprising, for example, from 2 to 30 mol of ethylene oxide; polyglycerolated fatty amides comprising, for example, from 1.5 to 5 glycerol groups, such as from 1.5 to 4; ethoxylated fatty acid esters of sorbitan comprising from 2 to 30 mol of ethylene oxide; ethoxylated oils from plant origin; fatty acid esters of sucrose; fatty acid esters of polyethylene glycol; polyethoxylated fatty acid mono or diesters of glycerol (C6-C24)alkylpolyglycosides; N—(C6-C24)alkylglucamine derivatives, amine oxides such as (C10-C14)alkylamine oxides or N—(C10-C14)acylaminopropylmorpholine oxides; and mixtures thereof.


The nonionic surfactants may preferably be chosen from polyoxyalkylenated or polyglycerolated nonionic surfactants. The oxyalkylene units are more particularly oxyethylene or oxypropylene units, or a combination thereof, and are preferably oxyethylene units.


In some cases, the nonionic surfactant may be selected from esters of polyols with fatty acids with a saturated or unsaturated chain containing for example from 8 to 24 carbon atoms, preferably 12 to 22 carbon atoms, and alkoxylated derivatives thereof, preferably with a number of alkyleneoxide of from 10 to 200, and more preferably from 10 to 100, such as glyceryl esters of a C8-C24, preferably C12-C22, fatty acid or acids and alkoxylated derivatives thereof, preferably with a number of alkyleneoxide of from 10 to 200, and more preferably from 10 to 100; polyethylene glycol esters of a C8-C24, preferably C12-C22, fatty acid or acids and alkoxylated derivatives thereof, preferably with a number of alkyleneoxide of from 10 to 200, and more preferably from 10 to 100; sorbitol esters of a C8-C24, preferably C12-C22, fatty acid or acids and alkoxylated derivatives thereof, preferably with a number of alkyleneoxide of from 10 to 200, and more preferably from 10 to 100; sugar (sucrose, glucose, alkylglycose) esters of a C8-C24, preferably C12-C22, fatty acid or acids and alkoxylated derivatives thereof, preferably with a number of alkyleneoxide of from 10 to 200, and more preferably from 10 to 100; ethers of fatty alcohols; ethers of sugar and a C8-C24, preferably C12-C22, fatty alcohol or alcohols; and mixtures thereof.


Examples of ethoxylated fatty esters that may be mentioned include the adducts of ethylene oxide with esters of lauric acid, palmitic acid, stearic acid or behenic acid, and mixtures thereof, especially those containing from 9 to 100 oxyethylene groups, such as PEG-9 to PEG-50 laurate (as the CTFA names: PEG-9 laurate to PEG-50 laurate); PEG-9 to PEG-50 palmitate (as the CTFA names: PEG-9 palmitate to PEG-50 palmitate); PEG-9 to PEG-50 stearate (as the CTFA names: PEG-9 stearate to PEG-50 stearate); PEG-9 to PEG-50 palmitostearate; PEG-9 to PEG-50 behenate (as the CTFA names: PEG-9 behenate to PEG-50 behenate); polyethylene glycol 100 EO monostearate (CTFA name: PEG-100 stearate); and mixtures thereof.


As glyceryl esters of fatty acids, glyceryl stearate (glyceryl mono-, di- and/or tristearate) (CTFA name: glyceryl stearate) or glyceryl ricinoleate and mixtures thereof can in particular be cited.


As glyceryl esters of C8-C24 alkoxylated fatty acids, polyethoxylated glyceryl stearate (glyceryl mono-, di- and/or tristearate) such as PEG-20 glyceryl stearate can for example be cited.


Mixtures of these surfactants, such as for example the product containing glyceryl stearate and PEG-100 stearate, marketed under the name ARLACEL 165 by Uniqema, and the product containing glyceryl stearate (glyceryl mono- and distearate) and potassium stearate marketed under the name TEG1 N by Goldschmidt (CTFA name: glyceryl stearate SE), can also be used.


Cationic Conditioning Agents


The cationic conditioning agents that may be employed in the compositions of the present disclosure can be a monoalkyl quaternary amine, such as stearyltrimonium chloride, soyatrimonium chloride or coco-ethyldimonium ethosulfate. Other suitable cationic conditioning agents include, but are not limited to, behentrimonium chloride, dialkyl quaternary amines, such as dicetyldimonium chloride, dicocodimethyl ammonium chloride or distearyldimethyl ammonium chloride; and polyquaternium compounds, such as Polyquaternium-6, Polyquaternium-22 or Polyquaternium-5.


For example, cationic conditioning agents may be chosen from polyquaterium-10 (also called quaternized polyhydroxyethyl cellulose), cetrimonium chloride (also called cetyl trimethyl ammonium chloride, CTAC), behentrimonium chloride (also known as docosyl trimethyl ammonium chloride), behentrimonium methosulfate, steartrimonium chloride, stearalkonium chloride, dicetyldimonium chloride, hydroxypropyltrimonium chloride, cocotrimonium methosulfate, olealkonium chloride, steartrimonium chloride, babassuamidopropalkonium chloride, brassicamidopropyl dimethylamine, Quaternium-91, Salcare/PQ-37, Quaternium-22, Quaternium-87, Polyquaternium-4, Polyquaternium-6, Polyquaternium-11, Polyquaternium-44, Polyquaternium-67, amodimethicone, lauryl betaine, Polyacrylate-1 Crosspolymer, steardimonium hydroxypropyl hydrolyzed wheat protein, behenamidopropyl PG-dimonium chloride, lauryldimonium hydroxypropyl hydrolyzed soy protein, aminopropyl dimethicone, Quaterium-8, and dilinoleamidopropyl dimethylamine dimethicone PEG-7 phosphate.


In some instances, the cationic conditioning agents are cationic polymers. The term “cationic polymer” means any polymer comprising at least one cationic group and/or at least one group that may be ionized into a cationic group.


Particularly useful cationic polymers in the present invention include, but are not limited to, polyquaternium 4, polyquaternium 6, polyquaternium 7, polyquaternium 10, polyquaternium 11, polyquaternium 16, polyquaternium 22, polyquaternium 28, polyquaternium 32, polyquaternium-46, polyquaternium-51, polyquaternium-52, polyquaternium-53, polyquaternium-54, polyquaternium-55, polyquaternium-56, polyquaternium-57, polyquaternium-58, polyquaternium-59, polyquaternium-60, polyquaternium-63, polyquaternium-64, polyquaternium-65, polyquaternium-66, polyquaternium-67, polyquaternium-70, polyquaternium-73, polyquaternium-74, polyquaternium-75, polyquaternium-76, polyquaternium-77, polyquaternium-78, polyquaternium-79, polyquaternium-80, polyquaternium-81, polyquaternium-82, polyquaternium-84, polyquaternium-85, polyquaternium-86, polyquaternium-87, polyquaternium-90, polyquaternium-91, polyquaternium-92, polyquaternium-94, and guar hydroxypropyltrimonium chloride.


Particularly preferred cationic polymers of the present invention include POLYMER JR-125, POLYMER JR-400, Polymer JR-30M hydroxyethyl cellulosic polymers (polyquaternium 10) available from AMERCHOL; JAGUAR C® 13-S, guar hydroxypropyltrimonium chloride, available from Rhodia; and MERQUAT® 100 and 280, a dimethyl dialkyl ammonium chloride (polyquaternium 6) available from Nalco.


The cationic polymer is generally present in an amount of from greater than 0% to about 15%, preferably from about 0.5% to about 10% by weight, and more preferably from about 1% to about 5% by weight, based on the total weight of the composition.


Cationic polymers useful herein include polyquaternium 4, polyquaternium 6, polyquaternium 7, polyquaternium 10, polyquaternium 11, polyquaternium 16, polyquaternium 22, and polyquaternium 32. Cationic polymers useful in the present invention include, but are not limited to, polyquaternium 4, polyquaternium 6, polyquaternium 7, polyquaternium 10, polyquaternium 11, polyquaternium 16, polyquaternium 22, polyquaternium 28, polyquaternium 32, and guar hydroxypropyltrimonium chloride. Preferred cationic polymers include POLYMER JR-125, POLYMER JR-400, Polymer JR-30M hydroxyethyl cellulosic polymers (polyquaternium 10) available from AMERCHOL; JAGUAR C13-S, guar hydroxypropyltrimonium chloride, available from Rhodia; and MERQUAT 100 and 280, a dimethyl dialkyl ammonium chloride (polyquaternium 6) available from Nalco.


Oils


The hair styling composition may include one or more oils, for example, silicone oils, fluoro oils, hydrocarbon-based oils, etc. The term “oil” means any fatty substance which is in liquid form at room temperature (20-25° C.) and at atmospheric pressure (760 mmHg). Often, at least one of the oils in the cosmetic composition is part of an oily phase. An “oily phase” is a phase comprising at least one oil that may include additional liposoluble and lipophilic ingredients and the fatty substances. The oily phase can be combined with an aqueous phase in an emulsion. Oil that is suitable for use herein may be volatile or non-volatile. The term “volatile oil” relates to oil that is capable of evaporating on contact with the skin or a keratin fiber in less than one hour, at room temperature and atmospheric pressure. The volatile oil(s) are liquid at room temperature and have a non-zero vapor pressure, at room temperature and atmospheric pressure, ranging in particular from 0.13 Pa to 40 000 Pa (10−3 to 300 mmHg). The term “non-volatile oil” relates to oil which remains on the skin or the keratin fiber, at room temperature and atmospheric pressure, for at least several hours and which in particular has a vapor pressure of less than 10−3 mmHg (0.13 Pa).


The term “silicone oil” relates to oil comprising at least one silicon atom, and especially at least one Si—O group. The term “fluoro oil” relates to oil comprising at least one fluorine atom. The term “hydrocarbon-based oil” relates to oil comprising mainly hydrogen and carbon atoms. Hydrocarbon-based oil may be animal hydrocarbon-based oil, plant hydrocarbon-based oil, mineral hydrocarbon-based oil or a synthetic hydrocarbon-based oil. Further, suitable oil may be a mineral hydrocarbon-based oil, a plant hydrocarbon-based oil, or a synthetic hydrocarbon-based oil.


Silicone Oils


The cosmetic compositions described herein may comprise one or more silicone oils. Non-limiting examples of silicone oils include dimethicone, cyclomethicone, polysilicone-11, phenyl trimethicone, trimethylsilylamodimethicone, and stearoxytrimethylsilane. In some cases, the cosmetic composition includes dimethicone, and optionally additional oils, including additional silicone oils. Typically, the one or more silicone oils is a non-volatile silicon oil. In some embodiments, the silicone oil is polydimethylsiloxanes (PDMSs), polydimethylsiloxanes comprising alkyl or alkoxy groups which are pendent and/or at the end of the silicone chain, which groups each contain from 2 to 24 carbon atoms, or phenyl silicones, such as phenyl trimethicones, phenyl dimethicones, phenyl(trimethylsiloxy)diphenylsiloxanes, diphenyl dimethicones, diphenyl(methyldiphenyl)trisiloxanes or (2-phenylethyl)trimethylsiloxysilicates.


Other examples of silicone oils that may be mentioned include volatile linear or cyclic silicone oils, especially those with a viscosity 8 centistokes (8×106 m2/s) and especially containing from 2 to 7 silicon atoms, these silicones optionally comprising alkyl or alkoxy groups containing from 1 to 10 carbon atoms. As volatile silicone oils that may be used in the invention, mention may be made especially of octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, heptamethylhexyltrisiloxane, heptamethyloctyltrisiloxane, hexamethyldisiloxane, octamethyltrisiloxane, decamethyltetrasiloxane and dodecamethylpentasiloxane, and mixtures thereof.


Fluoro Oils


The cosmetic compositions described herein may comprise one or more fluoro oils. For example, the onee or more fluoro oil may be selected from the group consisting of perfluoromethylcyclopentane, perfluoro-1,3-dimethylcyclohexane, dodecafluoropentane, tetradecafluorohexane, bromoperfluorooctyl, nonafluoromethoxybutane, nonafluoroethoxyisobutane and 4-trifluoromethylperfluoromorpholine. Volatile fluoro oils, such as nonafluoromethoxybutane, decafluoropentane, tetradecafluorohexane, dodecafluoropentane, may also be used.


Hydrocarbon-Based Oils


The cosmetic compositions described herein may comprise one or more hydrocarbon-based oils. For example, the hydrocarbon-based oil may be a saturated hydrocarbon, an unsaturated hydrocarbon, lipids, triglycerides, a natural oil, and/or a synthetic oil. In some embodiments, the compositions include a synthetic oil selected from the group consisting of hydrogenated polyisobutene and hydrogenated polydecene.


The hydrocarbon-based oil may be a non-volatile hydrocarbon-based, such as:

    • (i) hydrocarbon-based oils of plant origin, such as glyceride triesters, which are generally triesters of fatty acids and of glycerol, the fatty acids of which can have varied chain lengths from C4 to C24, it being possible for these chains to be saturated or unsaturated and linear or branched; these oils are in particular wheat germ oil, sunflower oil, grape seed oil, sesame oil, corn oil, apricot oil, castor oil, shea oil, avocado oil, olive oil, soybean oil, sweet almond oil, palm oil, rapeseed oil, cottonseed oil, hazelnut oil, macadamia oil, jojoba oil, alfalfa oil, poppy oil, pumpkin seed oil, marrow oil, blackcurrant oil, evening primrose oil, millet oil, barley oil, quinoa oil, rye oil, safflower oil, candlenut oil, passionflower oil, and musk rose oil.
    • (ii) synthetic ethers containing from 10 to 40 carbon atoms;
    • (iii) linear or branched hydrocarbons of mineral or synthetic origin, such as petroleum jelly, polydecenes, hydrogenated polyisobutene such as Parleam, and 40 squalane;
    • (iv) synthetic esters, for instance oils of formula RCOOR′ in which R represents a linear or branched fatty acid residue containing from 1 to 40 carbon atoms and R′ represents a hydrocarbon-based chain that is especially branched, containing from 1 to 40 carbon atoms on condition that R+R′ is ≥10, for instance Purcellin oil (cetearyl octanoate), isopropyl myristate, isopropyl palmitate, C12-C15 alkyl benzoate, such as the product sold under the trade name Finsolv TN® or Witconol TN® by Witco or Tegosoft TN® by Evonik Goldschmidt, 2-ethylphenyl benzoate, such as the commercial product sold under the name X-Tend 226 by ISP, isopropyl lanolate, hexyl laurate, diisopropyl adipate, isononyl isononanoate, oleyl erucate, 2-ethylhexyl palmitate, isostearyl isostearate, diisopropyl sebacate, such as the product sold under the name of “Dub Dis” by Stearinerie Dubois, octanoates, decanoates or ricinoleates of alcohols or polyalcohols, such as propylene glycol dioctanoate; hydroxylated esters, such as isostearyl lactate or diisostearyl malate; and pentaerythritol esters; citrates or tartrates, such as di(linear C12-C13 alkyl) tartrates, such as those sold under the name Cosmacol ETI® by Enichem Augusta Industriale, and also di(linear C14-C15 alkyl) tartrates, such as those sold under the name Cosmacol ETL® by the same company; or acetates;
    • (v) fatty alcohols that are liquid at room temperature, containing a branched and/or unsaturated carbon-based chain containing from 12 to 26 carbon atoms, for instance octyldodecanol, isostearyl alcohol, oleyl alcohol, 2-hexyldecanol, 2-butyloctanol or 2-undecylpentadecanol;
    • (vi) higher fatty acids, such as oleic acid, linoleic acid or linolenic acid;
    • (vii) carbonates, such as dicaprylyl carbonate, such as the product sold under the name Cetiol CC® by Cognis;
    • (viii) fatty amides, such as isopropyl N-lauroyl sarcosinate, such as the product sold under the trade name Eldew SL 205® from Ajinomoto; and
    • (ix) essential oils selected from the group consisting of sunflower oil, sesame oil, peppermint oil, macadamia nut oil, tea tree oil, evening primrose oil, sage oil, rosemary oil, coriander oil, thyme oil, pimento berries oil, rose oil, anise oil, balsam oil, bergamot oil, rosewood oil, cedar oil, chamomile oil, sage oil, clary sage oil, clove oil, cypress oil, eucalyptus oil, fennel oil, sea fennel oil, frankincense oil, geranium oil, ginger oil, grapefruit oil, jasmine oil, juniper oil, lavender oil, lemon oil, lemongrass oil, lime oil, mandarin oil, marjoram oil, myrrh oil, neroli oil, orange oil, patchouli oil, pepper oil, black pepper oil, petitgrain oil, pine oil, rose otto oil, rosemary oil, sandalwood oil, spearmint oil, spikenard oil, vetiver oil, wintergreen oil, and ylang ylang.


In certain instances, the non-volatile hydrocarbon-based oils are glyceride triesters and in particular to caprylic/capric acid triglycerides, synthetic esters and in particular isononyl isononanoate, oleyl erucate, C12-C15 alkyl benzoate, 2-ethylphenyl benzoate and fatty alcohols, such as octyldodecanol.


As volatile hydrocarbon-based oils, mention is made of hydrocarbon-based oils containing from 8 to 16 carbon atoms and in particular of branched C8-C16 alkanes, such as C8-C16 isoalkanes of petroleum origin (also known as isoparaffins), such as isododecane (also known as 2,2,4,4,6-pentamethylheptane), isodecane or isohexadecane, the oils sold under the Isopar or Permethyl trade names, branched C C8-C16 esters, and isohexyl neopentanoate.


Preservatives


One or more preservatives may be included in the compositions described herein for treating hair. Suitable preservatives include, but are not limited to, glycerin containing compounds (e.g., glycerin or ethylhexylglycerin or phenoxyethanol), benzyl alcohol, parabens (methylparaben, ethylparaben, propylparaben, butylparaben, isobutylparaben, etc.), sodium benzoate, ethylenediamine-tetraacetic acid (EDTA), potassium sorbate, and/or grapefruit seed extract, or combinations thereof. More than one preservative may be included in the composition. Other preservatives are known in the cosmetics industries and include salicylic acid, DMDM Hydantoin, Formaldahyde, Chlorphenism, Triclosan, Imidazolidinyl Urea, Diazolidinyl Urea, Sorbic Acid, Methylisothiazolinone, Sodium Dehydroacetate, Dehydroacetic Acid, Quaternium-15, Stearalkonium Chloride, Zinc Pyrithione, Sodium Metabisulfite, 2-Bromo-2-Nitropropane, Chlorhexidine Digluconate, Polyaminopropyl biguanide, Benzalkonium Chloride, Sodium Sulfite, Sodium Salicylate, Citric Acid, Neem Oil, Essential Oils (various), Lactic Acid, and Vitamin E (tocopherol).


The total amount of the one or more preservatives, when present, may vary. In some cases, the total amount of the one or more preservatives is about 0.01 to about 5 wt. %, about 0.01 to about 4 wt. %, about 0.15 to about 1 wt. %, or about 1 to about 3 wt. %, based on the total weight of the composition.


Suitable components, such as those listed in the instant disclosure (including those listed above), may be included or excluded from the hair styling compositions depending on the specific combination of other components, the form of the compositions, and/or the use of the formulation (e.g., hair spray, cream, paste, conditioner, etc.).


Methods


Another aspect of the invention pertains to methods of using the hair treatment compositions described herein. The methods generally comprise applying any of the hair treatment compositions described to hair. The hair treatment compositions may be useful in a variety of settings, and either for treated or untreated hair. Use on treated hair can include chemically relaxed hair. The hair treatment composition may be applied post relaxer but before neutralizing shampoo, after neutralizing shampoo, in or as a conditioner, or as a leave in treatment after the relaxation process. Use on untreated hair may include as part of a shampoo, part of a conditioner, as a pre-treatment, or after washing the hair as a leave-in treatment.


Methods of treating hair according to the disclosure may include applying a hair treatment composition of the instant disclosure to the hair (wet, damp, or dry hair), allowing the hair treatment to remain on the hair for a sufficient amount of time, and rinsing the hair treatment composition from the hair. The hair treatment composition may be applied to the hair before, during, or after other hair treatment compositions (e.g., a chemical relaxer composition, a shampoo, a conditioner, a lotion, a gel, etc.).


As mentioned previously, the hair treatment compositions are particularly useful for treating chemically treated hair. In some cases, a hair treatment composition is applied to the hair shortly after a chemical treatment composition is rinsed from the hair (e.g., within about 5, 10, 15, 20, or 30 minutes from when the chemical treatment composition is rinsed from the hair), while the hair is still wet or damp. The hair treatment composition may be allowed to remain on the hair for a period of time, for example from about a few seconds (1, 3, 5, or 10 seconds) to about 10, 20, or 30 minutes, or longer. In some cases, the hair treatment composition is applied to the chemically treated hair shortly after a chemical treatment composition is rinsed from the hair; and after applying the hair treatment composition, the hair is subsequently treated with a shampoo and/or a conditioner, or a conditioning shampoo (all-in-one shampoo/conditioner). The hair treatment composition may be rinsed from the hair prior to application of a shampoo and/or a conditioner, or a conditioning shampoo, or it may be allowed to remain on the hair during shampooing and/or conditioning and rinsed from the hair with the shampoo or the conditioner, or with the conditioning shampoo. For example, the hair treatment composition may be applied to the hair and without rinsing the hair treatment from the hair, a shampoo (or conditioner or conditioning shampoo) is subsequently applied to the hair (layered onto the hair treatment composition already applied to the hair). Both compositions (the hair treatment composition and the shampoo, conditioner, or conditioning shampoo) are rinsed from the hair together.


Moreover, the hair treatment composition may be combined with a shampoo and/or a conditioner, or with a conditioning shampoo, prior to application to the hair. Combining the hair treatment compositions with one or more additional hair treatment compositions (e.g., a shampoo, a conditioner, a conditioning shampoo, a rinse, etc.). For instance, the hair treatment composition may be mixed with a shampoo (or conditioner or conditioning shampoo) prior to application to the hair. In this case, the mixture of the shampoo (or conditioner or conditioning shampoo) and the hair treatment composition are simultaneously applied to the hair during the cleansing and/or conditioning process and simultaneously rinsed from the hair. Alternatively, the hair treatment composition may be layered on top of (or lathered into) hair to which a shampoo (or conditioner or conditioning shampoo) has already been applied or vice versa. In this case, the hair treatment composition may be applied to the hair first and without rinsing it from the hair, a shampoo (or conditioner or conditioning shampoo) is then subsequently applied to the hair. Alternatively, the shampoo (or conditioner or conditioning shampoo) may be first applied to the hair and without rinsing the shampoo (or conditioner or conditioning shampoo) from the hair, the hair treatment composition is also applied to the hair. Then, the compositions are simultaneously rinsed from the hair.


Described above is the individual application of a hair treatment composition or the combined or layered application of a hair treatment composition with another composition (e.g., a shampoo, conditioner, conditioning shampoo, etc.). In some cases, a hair treatment composition is individually applied to the hair and also combined or layered with another composition (e.g., a shampoo, conditioner, conditioning shampoo, etc.) that is also applied to the hair. For example, a hair treatment composition may be applied to the hair. Subsequently, with or without rinsing the hair treatment composition from the hair, another composition (e.g., a shampoo, conditioner, conditioning shampoo, etc.) in which the hair treatment composition has been mixed may be applied to the hair.


When combined with another composition (e.g., a shampoo, conditioner, conditioning shampoo, etc.), the hair treatment composition may be mixed with or used with in a ratio of about 1:10 to about 10:1, about 1:5 to about 5:1, about 1:3 to about 3:1, about 1:2 to about 2:1, about 1:1 to about 4:1, about 1:1 to about 3:1, or about 1:1 to about 2:1 (hair treatment composition of the instant disclosure:another composition).


The hair treatment compositions may be allowed to remain on the hair for a minimum amount of time before being rinsed from the hair, but allowing the hair treatment composition to remain on the hair for an extended period of time is not needed. Conveniently, the hair treatment compositions can be applied and allowed to remain on the hair for a period of time that is typical for regular shampooing and/or conditioning. For example, the hair treatment composition (whether combined with another hair treatment composition such as a shampoo or conditioner) may be applied to the hair and allowed to remain on the hair for a few seconds (1, 2, 3, 5, or 10 seconds) up to about 1, 2, 5, 10, 20, or 30 minutes, or longer.


When the hair treatment composition is not applied to the hair, simultaneously with another composition (e.g., a shampoo, conditioner, conditioning shampoo, etc.), the hair treatment composition may be applied to the hair immediately after or before the hair is treated with another composition (e.g., a shampoo, conditioner, conditioning shampoo, etc.). For example, the hair treatment compositions may be applied to the hair within about 1, 2, 5, 10, or 20 minutes before or after another composition is applied to the hair.


Kits


The hair treatment compositions of the instant disclosure may be incorporated into a kit. For example, the kits may include at least one hair treatment composition according to the instant disclosure and one or more additional hair treatment compositions, for example, a hair relaxer composition, a shampoo, a conditioner, etc. The various hair treatment compositions are separately contained in the kits. In some instances, the kits include one or more hair treatment compositions (according the instant disclosure), a shampoo, and/or a conditioner, all of which are separately contained. The kits may also include one or more hair treatment compositions (according the instant disclosure), a chemical relaxer composition, and optionally a shampoo and/or a conditioner. Instructions, mixing components, brushes, gloves, measuring tools, etc., may also be included in the kits.


Implementation of the present disclosure is provided by way of the following examples. The examples serve to illustrate the technology without being limiting in nature.


Example 1
Hair Treatment Composition
















Concentration



INCI Name
(wt. %)



















Maleic Acid
3.00



Lactic Acid
1.31



Ethanolamine
1.40



Inulin
2.91



Hexylene Glycol
1.50



Butylene Glycol
1.50



Water
61.32



Magnesium Sulfate
1.25



Propylene Glycol
0.03



Hydrogenated Starch Hydrolysate
1.05



Silicones
9.87



Polymers
3.53



Solvents
10.09



Misc. (Fragrance, preservative, etc.)
1.25










Example 2
Synergy of Ingredients

Testing was carried out to determine the influence of several ingredients. Several formulas containing a combination of ingredients as shown in the table below were applied to medium bleached hair swatches. The swatches were evaluated by several chemists with a 1-5 rating system for each of the attributes shown in the table. The same amount of each ingredient was used in the comparisons.




















Maleic acid &


Actives


Maleic acid &
Prosolvent &


Present
Inulin
Maleic acid
Prosolvent
Inulin







Strength: Hair

+
+
+++


mass






Strength: Hair

+
++
+++


body






Strength: Hair

+
++
+++


suppleness






Style: Fiber
++


+++


alignment






Style: Fiber
++


+++


definition






Style: closed
+


++


ends






Style:
++


+++


discipline






Style: shine
+


++





+ Signal is noticeable


++ Signal is pronounced


+++ Signal is very significant






The results show a synergistic effect when all three of inulin, maleic acid and prosolvent are present in all of the hair attributes.


The foregoing description illustrates and describes the disclosure. Additionally, the disclosure shows and describes only the preferred embodiments but, as mentioned above, it is to be understood that it is capable to use in various other combinations, modifications, and environments and is capable of changes or modifications within the scope of the invention concepts as expressed herein, commensurate with the above teachings and/or the skill or knowledge of the relevant art. The embodiments described herein above are further intended to explain best modes known by applicant and to enable others skilled in the art to utilize the disclosure in such, or other, embodiments and with the various modifications required by the particular applications or uses thereof. Accordingly, the description is not intended to limit the invention to the form disclosed herein. Also, it is intended to the appended claims be construed to include alternative embodiments.


As used herein, the terms “comprising,” “having,” and “including” (or “comprise,” “have,” and “include”) are used in their open, non-limiting sense.


The terms “a,” “an,” and “the” are understood to encompass the plural as well as the singular.


Thus, the term “a mixture thereof” also relates to “mixtures thereof.” Throughout the disclosure, the term “a mixture thereof” is used, following a list of elements as shown in the following example where letters A-F represent the elements: “one or more elements selected from the group consisting of A, B, C, D, E, F, and a mixture thereof.” The term, “a mixture thereof” does not require that the mixture include all of A, B, C, D, E, and F (although all of A, B, C, D, E, and F may be included). Rather, it indicates that a mixture of any two or more of A, B, C, D, E, and F can be included. In other words, it is equivalent to the phrase “one or more elements selected from the group consisting of A, B, C, D, E, F, and a mixture of any two or more of A, B, C, D, E, and F.”


Likewise, the term “a salt thereof” also relates to “salts thereof.” Thus, where the disclosure refers to “an element selected from the group consisting of A, B, C, D, E, F, a salt thereof, and a mixture thereof,” it indicates that that one or more of A, B, C, D, and F may be included, one or more of a salt of A, a salt of B, a salt of C, a salt of D, a salt of E, and a salt of F may be include, or a mixture of any two of A, B, C, D, E, F, a salt of A, a salt of B, a salt of C, a salt of D, a salt of E, and a salt of F may be included.


The salts, for example, the salts of the non-polymeric mono, di, and/or tricarboxylic acids, which are referred to throughout the disclosure may include salts having a counter-ion such as an alkali metal, alkaline earth metal, or ammonium counterion. This list of counterions, however, is non-limiting.


The expression “one or more” means “at least one” and thus includes individual components as well as mixtures/combinations.


Other than in the operating examples, or where otherwise indicated, all numbers expressing quantities of ingredients and/or reaction conditions are to be understood as being modified in all instances by the term “about,” meaning within +/−5% of the indicated number.


Some of the various categories of components identified for the various composition described herein, including the hair treatment compositions, may overlap. In such cases where overlap may exist between two or more components, a single overlapping compound does not represent more than one component. For example, a homopolymer of methyl quaternized dimethylaminoethyl methacrylate may be characterized as both a cationic polymer component and a thickening agent component. If a particular composition is described as including both a cationic polymer and a thickening agent, a single homopolymer of methyl quaternized dimethylaminoethyl methacrylate would serve as only the cationic polymer or only the thickening agent (the compound does not serve as both the cationic polymer and the thickening agent in the same composition).


All percentages, parts and ratios herein are based upon the total weight of the compositions of the present invention, unless otherwise indicated.


“Keratinous substrates” as used herein, includes, but is not limited to keratin fibers such as hair and/or scalp on the human head.


“Conditioning” as used herein means imparting to one or more hair fibers at least one property chosen from combability, moisture-retentivity, luster, shine, and softness. The state of conditioning can be evaluated by any means known in the art, such as, for example, measuring, and comparing, the ease of combability of the treated hair and of the untreated hair in terms of combing work (gm-in), and consumer perception.


The term “treat” (and its grammatical variations) as used herein refers to the application of the compositions of the present disclosure onto the surface of keratinous substrates such as hair. The term “treat,” and its grammatical variations, relates to contacting hair with the hair treatment compositions of the present disclosure.


The term “stable” as used herein means that the composition does not exhibit phase separation and/or crystallization for a period of time, for example, for at least 1 day (24 hours), one week, one month, or one year.


“Volatile”, as used herein, means having a flash point of less than about 100° C.


“Non-volatile”, as used herein, means having a flash point of greater than about 100° C.


All ranges and values disclosed herein are inclusive and combinable. For examples, any value or point described herein that falls within a range described herein can serve as a minimum or maximum value to derive a sub-range, etc. Furthermore, all ranges provided are meant to include every specific range within, and combination of sub-ranges between, the given ranges. Thus, a range from 1-5, includes specifically 1, 2, 3, 4 and 5, as well as sub ranges such as 2-5, 3-5, 2-3, 2-4, 1-4, etc.


The term “substantially free” or “essentially free” as used herein means that there is less than about 5% by weight of a specific material added to a composition, based on the total weight of the compositions. Nonetheless, the compositions may include less than about 3 wt. %, less than about 2 wt. %, less than about 1 wt. %, less than about 0.5 wt. %, less than about 0.1 wt. %, or none of the specified material.


All publications and patent applications cited in this specification are herein incorporated by reference, and for any and all purposes, as if each individual publication or patent application were specifically and individually indicated to be incorporated by reference. In the event of an inconsistency between the present disclosure and any publications or patent application incorporated herein by reference, the present disclosure controls.

Claims
  • 1. A hair treatment composition comprising: at least 0.5 wt. % of one or more carboxylic acids chosen from non-polymeric mono, di, or tricarboxylic acids, salts thereof, or mixtures thereof;one or more amines chosen from diamines, polyamines, alkylamines, alkanolamines, or mixtures thereof;one or more fructan polysaccharides chosen from levan polysaccharides;one or more prosolvents; andwater.
  • 2. The hair treatment composition of claim 1, wherein the one or more carboxylic acids comprises a dicarboxylic acid and/or a salt thereof.
  • 3. The hair treatment composition of claim 2, wherein the dicarboxylic acid is chosen from oxalic acid, malonic acid, malic acid, glutaric acid, citraconic acid, succinic acid, adipic acid, tartaric acid, fumaric acid, maleic acid, sebacic acid, azelaic acid, dodecanedioic acid, phthalic acid, isophthalic acid, terephthalic acid, 2,6-naphthalene dicarboxylic acid, salts thereof, or mixtures thereof.
  • 4. The hair treatment composition of claim 3, wherein the at least one dicarboxylic acid is maleic acid, malonic acid, salts thereof, or mixtures thereof.
  • 5. The hair treatment composition of claim 1, comprising at least one tricarboxylic acid chosen from citric acid, isocitric acid, aconitric acid, propane-1,2,3-tricarboxylic acid, benzene-1,3,5-tricarboxylic acid, salts thereof, or mixtures thereof.
  • 6. The hair treatment composition of claim 5, wherein the at least one tricarboxylic acid is citric acid, a salt thereof, or a mixture thereof.
  • 7. The hair treatment composition of claim 1, wherein the total amount of the one or more carboxylic acids chosen from non-polymeric mono, di, or tricarboxylic acids, salts thereof, or mixtures thereof ranges from 0.5 wt. % to about 20 wt. %, based on the total weight of the hair treatment composition.
  • 8. The hair treatment composition of claim 1, comprising one or more alkylamine and/or alkanolamine compound of formula (II): NR3R4R5  (II)wherein R3, R4, and R5 are independently H, C1-C40 alkyl, C1-C40 monohydroxyalkyl, or C2-C40 polyhydroxyalkyl, provided that at least one of R3, R4, and R5 is an alkyl or monohydroxyalkyl or polyhydroxyalkyl.
  • 9. The hair treatment composition of claim 8, comprising one or more alkanolamines chosen from monoethanolamine, diethanolamine, triethanolamine, monoisopropanolamine, diisopropanolamine, N-dimethylamino-ethanolamine, 2-amino-2-methyl-1-propanol, triisopropanolamine, 2-amino-2-methyl-1,3-propanediol, 3-amino-1,2-propanediol, 3-dimethylamino-1,2-propanediol, tris(hydroxymethylamino)methane, or mixtures thereof.
  • 10. The hair treatment composition of claim 9, comprising monoethanolamine.
  • 11. The hair treatment composition of claim 1, wherein the total amount of the one or more amines ranges from about 1 wt. % to about 20 wt. %, based on the total weight of the hair treatment composition.
  • 12. The hair treatment composition of claim 1, further comprising one or more inulin polysaccharides.
  • 13. The hair treatment composition of claim 1, wherein the total amount of the one or more fructan polysaccharides ranges from about 1 wt. % to about 5 wt. %, based on the total weight of the hair treatment composition.
  • 14. The hair treatment composition of claim 1, wherein the one or more prosolvents is chosen from hexylene glycol, butylene glycol, propylene glycol, or mixtures thereof.
  • 15. A hair treatment composition comprising: about 2 wt. % to about 4 wt. % of maleic acid, a salt thereof, or a mixture thereof;about 1 wt. % to about 3 wt. % of monoethanolamine;about 1 wt. % to about 5 wt. % of one or more levan polysaccharides;about 2 wt. % to about 4 wt. % of a mixture of hexylene glycol and butylene glycol; andwater.
  • 16. A method of treating hair, the method comprising: applying to the hair a hair treatment composition comprising: at least 0.5 wt. % of one or more carboxylic acids chosen from non-polymeric mono, di, or tricarboxylic acids, salts thereof, or mixtures thereof;one or more amines chosen from diamines, polyamines, alkylamines, alkanolamines, or mixtures thereof;one or more fructan polysaccharides chosen from levan polysaccharides;one or more prosolvents; andwater.
  • 17. The method of claim 16, wherein the composition is applied to hair as part of a shampoo or conditioning routine.
  • 18. The method of claim 17, wherein the composition is applied after a chemical relaxer is applied to the hair.
  • 19. A method of treating hair, the method comprising: applying to the hair a hair treatment composition comprising: about 2 wt. % to about 4 wt. % of maleic acid, a salt thereof, or a mixture thereof;about 1 wt. % to about 3 wt. % of monoethanolamine;about 1 wt. % to about 5 wt. % of one or more levan polysaccharides;about 2 wt. % to about 4 wt. % of a mixture of hexylene glycol and butylene glycol; andwater.
CROSS REFERENCE TO RELATED APPLICATION

This is a continuation of U.S. application Ser. No. 16/176,350 filed on Oct. 31, 2018, which is incorporated herein by reference in its entirety.

US Referenced Citations (384)
Number Name Date Kind
2261002 Ritter Oct 1941 A
2271378 Searle Jan 1942 A
2273780 Dittmar Feb 1942 A
2375853 Kirby et al. May 1945 A
2388614 Kirby et al. Nov 1945 A
2454547 Bock et al. Nov 1948 A
2674580 Henkin Apr 1954 A
2850351 Moore et al. Sep 1958 A
2961347 Floyd Nov 1960 A
3142623 Zviak et al. Jul 1964 A
3193464 Edman et al. Jul 1965 A
3206462 McCarty Sep 1965 A
3227615 Korden Jan 1966 A
3288770 Butler Nov 1966 A
3412019 Hoover et al. Nov 1968 A
3472243 Wall et al. Oct 1969 A
3472840 Stone et al. Oct 1969 A
3589978 Kamal et al. Jun 1971 A
3632559 Matter et al. Jan 1972 A
3766267 Zak et al. Oct 1973 A
3840656 Kalopissis et al. Oct 1974 A
3874870 Green et al. Apr 1975 A
3917817 Vanlerberghe et al. Nov 1975 A
3929990 Green et al. Dec 1975 A
3966904 Green et al. Jun 1976 A
4001432 Green et al. Jan 1977 A
4003699 Rose et al. Jan 1977 A
4005193 Green et al. Jan 1977 A
4012398 Conner et al. Mar 1977 A
4013787 Vanlerberghe et al. Mar 1977 A
4025617 Green et al. May 1977 A
4025627 Green et al. May 1977 A
4025653 Green et al. May 1977 A
4026945 Green et al. May 1977 A
4027020 Green et al. May 1977 A
4031307 DeMartino et al. Jun 1977 A
4075136 Schaper Feb 1978 A
4131576 Tovine et al. Dec 1978 A
4166894 Schaper Sep 1979 A
4172887 Vanlerberghe et al. Oct 1979 A
RE30199 Rose et al. Jan 1980 E
4189468 Vanlerberghe et al. Feb 1980 A
4197865 Jacquet et al. Apr 1980 A
4217914 Jacquet et al. Aug 1980 A
4240450 Grollier et al. Dec 1980 A
4277581 Vanlerberghe et al. Jul 1981 A
4348202 Grollier et al. Sep 1982 A
4349532 Vanlerberghe et al. Sep 1982 A
4381919 Jacquet et al. May 1983 A
4412943 Hirota et al. Nov 1983 A
4422853 Jacquet et al. Dec 1983 A
4425132 Grollier et al. Jan 1984 A
4532950 Lang et al. Aug 1985 A
4579732 Grollier et al. Apr 1986 A
4591610 Grollier May 1986 A
4608250 Jacquet et al. Aug 1986 A
4734277 Login Mar 1988 A
4761273 Grollier et al. Aug 1988 A
4770873 Wolfram et al. Sep 1988 A
4772462 Boothe et al. Sep 1988 A
4777040 Grollier et al. Oct 1988 A
4793992 Mathews et al. Dec 1988 A
4793993 Siuta-Mangano et al. Dec 1988 A
4812307 Siuta-Mangano Mar 1989 A
4834971 Klenk et al. May 1989 A
4855130 Konrad et al. Aug 1989 A
4906460 Kim et al. Mar 1990 A
4948579 Jacquet et al. Aug 1990 A
4970066 Grollier et al. Nov 1990 A
5061289 Clausen et al. Oct 1991 A
5085860 Junino et al. Feb 1992 A
5091171 Yu et al. Feb 1992 A
5143518 Madrange et al. Sep 1992 A
5196189 Jacquet et al. Mar 1993 A
5221286 Singleton et al. Jun 1993 A
5293885 Darkwa et al. Mar 1994 A
5350572 Savaides et al. Sep 1994 A
5356438 Kim et al. Oct 1994 A
5380340 Neunhoeffer et al. Jan 1995 A
5534267 Neunhoeffer et al. Jul 1996 A
5565216 Cowsar et al. Oct 1996 A
5593662 Deckner et al. Jan 1997 A
5616150 Moeller et al. Apr 1997 A
5628991 Samain et al. May 1997 A
5635168 Burns et al. Jun 1997 A
5651960 Chan et al. Jul 1997 A
5656265 Bailey et al. Aug 1997 A
5663366 Neunhoeffer et al. Sep 1997 A
5688291 Said et al. Nov 1997 A
5708151 Möckli Jan 1998 A
5750099 Yoshihara et al. May 1998 A
5766576 Löwe et al. Jun 1998 A
5785962 Hinz et al. Jul 1998 A
5811085 Halloran Sep 1998 A
5833966 Samain Nov 1998 A
5853706 Klar Dec 1998 A
5853706 Klar Dec 1998 A
5853707 Wells et al. Dec 1998 A
5869068 De Lacharriere et al. Feb 1999 A
5951969 Golinski et al. Sep 1999 A
5972322 Rath et al. Oct 1999 A
5985803 Rizvi et al. Nov 1999 A
6013250 Cannell et al. Jan 2000 A
6015574 Cannell et al. Jan 2000 A
6036966 Youssefyeh Mar 2000 A
6090762 Clapperton et al. Jul 2000 A
6099592 Vidal et al. Aug 2000 A
6173717 Schonert et al. Jan 2001 B1
6231843 Hoelzel et al. May 2001 B1
6241971 Fox et al. Jun 2001 B1
6284003 Rose et al. Sep 2001 B1
6309426 Dias et al. Oct 2001 B1
6338741 Vidal et al. Jan 2002 B1
6348189 Tanabe et al. Feb 2002 B1
6348200 Nakajima et al. Feb 2002 B1
6358502 Tanabe et al. Mar 2002 B1
6398821 Dias et al. Jun 2002 B1
6458906 Torgerson et al. Oct 2002 B1
6488945 Sato Dec 2002 B2
6515050 Mitsuzuka et al. Feb 2003 B1
6537532 Torgerson et al. Mar 2003 B1
6562327 Nguyen et al. May 2003 B1
6569412 Yamaguchi et al. May 2003 B2
6645258 Vidal et al. Nov 2003 B2
6645478 Rollat et al. Nov 2003 B2
6669933 Duffer et al. Dec 2003 B2
6706258 Gallagher et al. Mar 2004 B1
6730789 Birault et al. May 2004 B1
6767875 Snyder et al. Jul 2004 B1
6979439 Sakai et al. Dec 2005 B1
6984250 Legrand et al. Jan 2006 B1
7041142 Chan et al. May 2006 B2
7044986 Ogawa et al. May 2006 B2
7135167 Legrand et al. Nov 2006 B2
7147843 Yoshida et al. Dec 2006 B2
7151079 Fack et al. Dec 2006 B2
7204861 Marsh et al. Apr 2007 B2
7390479 Sockel et al. Jun 2008 B2
7427656 Decarolis et al. Sep 2008 B2
7495037 Moszner et al. Feb 2009 B2
7598213 Geary et al. Oct 2009 B2
7612141 Sakai et al. Nov 2009 B2
7815901 Mathonneau et al. Oct 2010 B2
7905926 DeGeorge et al. Mar 2011 B2
7915208 Roso et al. Mar 2011 B2
7931698 Simonet et al. Apr 2011 B2
7972388 Hamilton et al. Jul 2011 B2
7981405 Ueyama et al. Jul 2011 B2
8163861 Puerta et al. Apr 2012 B2
8241370 Legrand et al. Aug 2012 B2
8288329 Hata et al. Oct 2012 B2
8298519 Adams et al. Oct 2012 B2
8357356 Zaeska et al. Jan 2013 B2
8388701 Uellner et al. Mar 2013 B2
8513200 Dixon et al. Aug 2013 B2
8613913 Chang et al. Dec 2013 B2
8632758 Terada Jan 2014 B2
8642021 Brautigam et al. Feb 2014 B2
8921292 Fujita et al. Dec 2014 B2
9006162 Rizk Apr 2015 B1
9044409 Carola et al. Jun 2015 B2
9095518 Pressly et al. Aug 2015 B2
9114088 Konno et al. Aug 2015 B2
9144537 Pressly et al. Sep 2015 B1
9175114 Puerta et al. Nov 2015 B2
9180086 Cabourg et al. Nov 2015 B2
9283156 Savaides et al. Mar 2016 B2
9326926 Pressly et al. May 2016 B2
9402796 Briggs et al. Aug 2016 B2
9498419 Pressly et al. Nov 2016 B2
9597273 Pressly et al. Mar 2017 B2
9610241 Cabourg et al. Apr 2017 B2
9849071 Fack et al. Dec 2017 B2
9918923 Naiberk et al. Mar 2018 B1
9993406 Manneck et al. Jun 2018 B2
10004673 Elsen-Wahrer et al. Jun 2018 B1
10085931 Baghdadli et al. Oct 2018 B2
10219994 Lechner et al. Mar 2019 B2
10231915 Dreher et al. Mar 2019 B2
10561599 Patterson et al. Feb 2020 B2
10576307 Patterson et al. Mar 2020 B2
11596588 Machover et al. Mar 2023 B2
20010029637 Nakashimada et al. Oct 2001 A1
20010042276 Kawasoe et al. Nov 2001 A1
20010052354 Nishibe et al. Dec 2001 A1
20020029429 Dias et al. Mar 2002 A1
20020032933 Dias et al. Mar 2002 A1
20020050013 Vidal et al. May 2002 A1
20020053110 Dias et al. May 2002 A1
20020155081 Coope Oct 2002 A1
20020189034 Kitabata et al. Dec 2002 A1
20030012761 Yoshida et al. Jan 2003 A1
20030019051 Vidal et al. Jan 2003 A9
20030049222 Akhter et al. Mar 2003 A1
20030072962 Matsuzaki et al. Apr 2003 A1
20030074743 Noguchi et al. Apr 2003 A1
20030083380 Yu et al. May 2003 A1
20030152543 Legrand et al. Aug 2003 A1
20030215415 Mitsumatsu et al. Nov 2003 A1
20040034944 Legrand et al. Feb 2004 A1
20040034946 Legrand et al. Feb 2004 A1
20040067212 Tokuyama et al. Apr 2004 A1
20040086475 Boswell et al. May 2004 A1
20040088800 Cotteret May 2004 A1
20040156877 Tokuyama et al. Aug 2004 A1
20040181883 Legrand et al. Sep 2004 A1
20040202689 Subramanyan et al. Oct 2004 A1
20040216244 Cotteret et al. Nov 2004 A1
20040228580 Lee et al. Nov 2004 A1
20040241114 Gupta Dec 2004 A1
20040256598 Plos et al. Dec 2004 A1
20040258652 Pascaly et al. Dec 2004 A1
20050015894 Cottard et al. Jan 2005 A1
20050036970 Sabbagh et al. Feb 2005 A1
20050087718 Okada Apr 2005 A1
20050095215 Popp May 2005 A1
20050176615 Kinoshita et al. Aug 2005 A1
20050186164 Akyuz Aug 2005 A1
20050191263 Ueyama et al. Sep 2005 A1
20050193501 Chan et al. Sep 2005 A1
20050201966 Ueyama et al. Sep 2005 A1
20060024257 Chang et al. Feb 2006 A1
20060045862 Tada et al. Mar 2006 A1
20060062751 Sato et al. Mar 2006 A1
20060075580 Chan et al. Apr 2006 A1
20060093571 Glinski May 2006 A1
20060135397 Bissey-Beugras et al. Jun 2006 A1
20060166845 Terada Jul 2006 A1
20060182702 Lazzeri et al. Aug 2006 A1
20060198807 Morioka Sep 2006 A1
20060228316 Cannell et al. Oct 2006 A1
20060251673 Hwang et al. Nov 2006 A1
20060276369 Levecke et al. Dec 2006 A1
20070041921 Neill et al. Feb 2007 A1
20070067924 Beck et al. Mar 2007 A1
20070107142 Nguyen et al. May 2007 A1
20070116661 Mata May 2007 A1
20070160560 Laurent et al. Jul 2007 A1
20070161543 Yu et al. Jul 2007 A1
20070190008 Campain et al. Aug 2007 A1
20070261594 Vaskelis et al. Nov 2007 A1
20070264208 Mougin et al. Nov 2007 A1
20080025937 Cassier Jan 2008 A1
20080025939 Cassier et al. Jan 2008 A1
20080066773 Anderson et al. Mar 2008 A1
20080118458 Giesen et al. May 2008 A1
20080124295 Duranton et al. May 2008 A1
20080138309 Malle et al. Jun 2008 A1
20080141468 Cotteret Jun 2008 A1
20080187506 Carballada et al. Aug 2008 A1
20080226576 Benabdillah et al. Sep 2008 A1
20080233072 Bureiko et al. Sep 2008 A1
20080306025 Yu et al. Dec 2008 A1
20090022681 Carballada et al. Jan 2009 A1
20090041699 Molenda et al. Feb 2009 A1
20090041701 Taylor Feb 2009 A1
20090041713 Taylor Feb 2009 A1
20090053165 Brown et al. Feb 2009 A1
20090071493 Nguyen et al. Mar 2009 A1
20090074683 Nguyen et al. Mar 2009 A1
20090126756 Syed et al. May 2009 A1
20090208499 Yu et al. Aug 2009 A1
20090214628 de Rijk Aug 2009 A1
20090252697 Barbarat et al. Oct 2009 A1
20090274677 Isaacs et al. Nov 2009 A1
20100004391 Haddleton et al. Jan 2010 A1
20100015079 Schrader Jan 2010 A1
20100081716 Matsunaga et al. Apr 2010 A1
20100119468 Garcia Castro et al. May 2010 A1
20100154140 Simonet et al. Jun 2010 A1
20100158845 Ellington et al. Jun 2010 A1
20100158964 Cunningham et al. Jun 2010 A1
20100178267 Puerta et al. Jul 2010 A1
20100189795 Dreher Jul 2010 A1
20100202998 Ramos-Stanbury et al. Aug 2010 A1
20100247463 Yu et al. Sep 2010 A1
20100303748 Hercouet Dec 2010 A1
20110056508 Gross et al. Mar 2011 A1
20110061671 Neplaz et al. Mar 2011 A1
20110142778 Hloucha et al. Jun 2011 A1
20110150804 Nojiri Jun 2011 A1
20110213033 Tokuyama et al. Sep 2011 A1
20110256084 Dixon et al. Oct 2011 A1
20110311463 Diamond et al. Dec 2011 A1
20120015894 Terada Jan 2012 A1
20120022037 Terada Jan 2012 A1
20120064137 Kawai Mar 2012 A1
20120114583 Giesen et al. May 2012 A1
20120118316 Uellner et al. May 2012 A1
20120121705 Paus et al. May 2012 A1
20120142569 Cao et al. Jun 2012 A1
20120142569 Cao et al. Jun 2012 A1
20120180807 Flohr Jul 2012 A1
20120230935 Kim et al. Sep 2012 A1
20120244082 Sulzbach et al. Sep 2012 A1
20120288459 Burg et al. Nov 2012 A1
20120329650 Lopez-Cervantes Dec 2012 A1
20130016246 Hatanaka et al. Jan 2013 A1
20130034515 Stone et al. Feb 2013 A1
20130102513 Terada Apr 2013 A1
20130118996 Kaplan May 2013 A1
20130142748 Tamura et al. Jun 2013 A1
20130142748 Tamura et al. Jun 2013 A1
20130149274 Nguyen et al. Jun 2013 A1
20130152959 Genain et al. Jun 2013 A1
20130156716 Yontz Jun 2013 A1
20130164240 Schrott Jun 2013 A1
20130172518 Huang et al. Jul 2013 A1
20130216491 Ogihara et al. Aug 2013 A1
20130233331 Khenniche et al. Sep 2013 A1
20130233332 Khenniche et al. Sep 2013 A1
20130251656 Khenniche et al. Sep 2013 A1
20130266529 Deconinck et al. Oct 2013 A1
20130280199 Albert et al. Oct 2013 A1
20130309190 Dimotakis et al. Nov 2013 A1
20130315852 Streuli Nov 2013 A1
20140120047 Krueger May 2014 A1
20140158150 Schoepgens et al. Jun 2014 A1
20140170105 Chen et al. Jun 2014 A1
20140171354 Miralles et al. Jun 2014 A1
20140186283 Cabourg et al. Jul 2014 A1
20140196741 Cabourg et al. Jul 2014 A1
20140246041 Krueger Sep 2014 A1
20140256885 Puerta et al. Sep 2014 A1
20150004117 Tan et al. Jan 2015 A1
20150004119 Tan et al. Jan 2015 A1
20150034117 Pressly et al. Feb 2015 A1
20150034119 Pressly et al. Feb 2015 A1
20150037270 Pressly et al. Feb 2015 A1
20150037271 Pressly et al. Feb 2015 A1
20150053228 Bonauer et al. Feb 2015 A1
20150053230 Myatt Feb 2015 A1
20150090285 Worner et al. Apr 2015 A1
20150157544 Briggs et al. Jun 2015 A1
20150252302 Rieth et al. Sep 2015 A1
20150283041 Benn et al. Oct 2015 A1
20150290101 Pressly et al. Oct 2015 A1
20150297496 Kroon et al. Oct 2015 A1
20150305469 Paul Oct 2015 A1
20150313816 Daubresse Nov 2015 A1
20150328102 Pressly et al. Nov 2015 A1
20160058688 Anderheggen et al. Mar 2016 A1
20160081899 Pressly et al. Mar 2016 A1
20160166479 Chiou et al. Jun 2016 A1
20160175238 Shin et al. Jun 2016 A1
20160193129 Pressly et al. Jul 2016 A1
20160235649 Streuli Aug 2016 A1
20160263003 Pressly et al. Sep 2016 A1
20160310394 Pressly et al. Oct 2016 A1
20160331664 Anderheggen et al. Nov 2016 A1
20160348037 Findlay et al. Dec 2016 A1
20170007518 Everaert et al. Jan 2017 A1
20170112740 Schoepgens et al. Apr 2017 A1
20170112743 Schoepgens et al. Apr 2017 A1
20170113071 Schoepgens et al. Apr 2017 A1
20170119122 Rautenberg-Groth et al. May 2017 A1
20170128334 Schoepgens et al. May 2017 A1
20170128342 Schoepgens et al. May 2017 A1
20170143611 Hippe et al. May 2017 A1
20170151143 Scheunemann et al. Jun 2017 A1
20170151144 Scheunemann et al. Jun 2017 A1
20170151146 Scheunemann et al. Jun 2017 A1
20170151147 Scheunemann et al. Jun 2017 A1
20170151156 Scheunemann et al. Jun 2017 A1
20170157011 Punyani et al. Jun 2017 A1
20170165161 Manneck et al. Jun 2017 A1
20170202763 Manneck et al. Jul 2017 A1
20170246094 Dreher et al. Aug 2017 A1
20170252291 Lechner et al. Sep 2017 A1
20170360658 Ferrari et al. Dec 2017 A1
20180055751 Gevgilili et al. Mar 2018 A1
20180116942 Mahadeshwar et al. May 2018 A1
20180140531 Singer et al. May 2018 A1
20180140532 Singer et al. May 2018 A1
20180280267 Rughani et al. Oct 2018 A1
20180280269 Rughani et al. Oct 2018 A1
20180280270 Rughani et al. Oct 2018 A1
20180280271 Fack et al. Oct 2018 A1
20180338895 Patterson et al. Nov 2018 A1
20180338901 Patterson et al. Nov 2018 A1
20180339175 Patterson et al. Nov 2018 A1
20190160000 Herrlein et al. May 2019 A1
20190201309 Machover et al. Jul 2019 A1
20200129405 Mitchell et al. Apr 2020 A1
Foreign Referenced Citations (255)
Number Date Country
1383377 Dec 2002 CN
1423548 Jun 2003 CN
1424016 Jun 2003 CN
1454074 Nov 2003 CN
1678281 Oct 2005 CN
1717215 Jan 2006 CN
1778289 May 2006 CN
1798539 Jul 2006 CN
101282705 Oct 2008 CN
101495087 Jul 2009 CN
101686920 Mar 2010 CN
101843561 Sep 2010 CN
101966136 Feb 2011 CN
102056896 May 2011 CN
102166163 Aug 2011 CN
102231974 Nov 2011 CN
102281864 Dec 2011 CN
102361627 Feb 2012 CN
102397232 Apr 2012 CN
102451117 May 2012 CN
103356395 Oct 2013 CN
103998099 Aug 2014 CN
104066419 Sep 2014 CN
104066423 Sep 2014 CN
104066423 Sep 2014 CN
104159567 Nov 2014 CN
104519962 Apr 2015 CN
105267066 Jan 2016 CN
105902403 Aug 2016 CN
105902404 Aug 2016 CN
106265109 Jan 2017 CN
1220969 Jul 1966 DE
2225541 Dec 1973 DE
2359399 Jun 1976 DE
3843892 Jun 1990 DE
4133957 Apr 1993 DE
4300320 Jul 1994 DE
19543988 May 1997 DE
29722990 May 1999 DE
10051773 Apr 2002 DE
10051774 Apr 2002 DE
20208254 Aug 2002 DE
102004052480 May 2006 DE
102007039745 Feb 2009 DE
202015104742 Oct 2015 DE
102014213317 Jan 2016 DE
102015223828 Sep 2016 DE
102015221460 May 2017 DE
102016200688 Jul 2017 DE
202017001430 Jul 2017 DE
0122324 Oct 1984 EP
0159628 Oct 1985 EP
0286261 Oct 1988 EP
0298684 Jan 1989 EP
0299764 Jan 1989 EP
0437114 Jul 1991 EP
0512879 Nov 1992 EP
0636358 Feb 1995 EP
0714954 Jun 1996 EP
0770375 May 1997 EP
0855178 Jul 1998 EP
0978272 Feb 2000 EP
1118319 Jul 2001 EP
1174112 Jan 2002 EP
1216023 Apr 2005 EP
1541117 Jun 2005 EP
1570832 Sep 2005 EP
1216022 Apr 2006 EP
1690524 Aug 2006 EP
1779896 May 2007 EP
1810657 Jul 2007 EP
2123250 Nov 2009 EP
2165697 Mar 2010 EP
2229933 Sep 2010 EP
2295029 Mar 2011 EP
2460511 Jun 2012 EP
2471504 Jul 2012 EP
2478892 Jul 2012 EP
1510197 Mar 2016 EP
1492597 Aug 1967 FR
1583363 Oct 1969 FR
2162025 Jul 1973 FR
2252840 Jun 1975 FR
2270846 Dec 1975 FR
2280361 Feb 1976 FR
2316271 Jan 1977 FR
2320330 Mar 1977 FR
2336434 Jul 1977 FR
2368508 May 1978 FR
2413907 Aug 1979 FR
2505348 Nov 1982 FR
2542997 Sep 1984 FR
2733749 Nov 1996 FR
2789895 Aug 2000 FR
2789896 Aug 2000 FR
2801308 May 2001 FR
2841129 Dec 2003 FR
2886136 Dec 2006 FR
2939030 Jun 2010 FR
2944441 Oct 2010 FR
2966352 Apr 2012 FR
2975899 Dec 2012 FR
2975900 Dec 2012 FR
713675 Aug 1954 GB
741307 Nov 1955 GB
773559 Apr 1957 GB
1026978 Apr 1966 GB
1125794 Aug 1968 GB
1153196 May 1969 GB
1260451 Jan 1972 GB
1546809 May 1979 GB
1584364 Feb 1981 GB
2270259 Mar 1994 GB
2270259 Mar 1994 GB
S60-158105 Aug 1985 JP
S62-212313 Sep 1987 JP
63-154611 Jun 1988 JP
S63-239209 Oct 1988 JP
S63-255214 Oct 1988 JP
02-019576 Jan 1990 JP
H02-138110 May 1990 JP
05-163124 Jun 1993 JP
H07-069847 Mar 1995 JP
08-198732 Aug 1996 JP
H08-509478 Oct 1996 JP
H09-249538 Sep 1997 JP
H10-203923 Aug 1998 JP
2000-229821 Aug 2000 JP
2001-081013 Mar 2001 JP
2002-097115 Apr 2002 JP
2002-105493 Apr 2002 JP
2002-121121 Apr 2002 JP
2002-356408 Dec 2002 JP
2002-363048 Dec 2002 JP
2003-095876 Apr 2003 JP
2003-516335 May 2003 JP
2004-026834 Jan 2004 JP
2004-026976 Jan 2004 JP
2005-060398 Mar 2005 JP
2005-154348 Jun 2005 JP
2006-052178 Feb 2006 JP
2006-219493 Aug 2006 JP
2006-316012 Nov 2006 JP
2006-327994 Dec 2006 JP
2008-169183 Jul 2008 JP
2008-189686 Aug 2008 JP
2009-007283 Jan 2009 JP
2009-078992 Apr 2009 JP
2009-536619 Oct 2009 JP
2010-155823 Jul 2010 JP
2011-042586 Mar 2011 JP
2012-515218 Jul 2012 JP
2013-500328 Jan 2013 JP
2015-086211 May 2015 JP
2016-003185 Jan 2016 JP
2017-095451 Jun 2017 JP
2018-514570 Jun 2018 JP
10-2001-0039848 Jul 2001 KR
10-2003-0003970 Jan 2003 KR
10-2004-0098688 Nov 2004 KR
10-2006-0059564 Jun 2006 KR
10-2012-0062511 Jun 2012 KR
10-2016-0064420 Jun 2016 KR
2144945 Jan 2000 RU
2229281 May 2004 RU
9300882 Jan 1993 WO
9308787 May 1993 WO
9408969 Apr 1994 WO
9408970 Apr 1994 WO
9501152 Jan 1995 WO
9501772 Jan 1995 WO
9515144 Jun 1995 WO
9615765 May 1996 WO
9724106 Jul 1997 WO
9856333 Dec 1998 WO
9911226 Mar 1999 WO
9966793 Dec 1999 WO
0135912 May 2001 WO
0147486 Jul 2001 WO
0152005 Jul 2001 WO
0219976 Mar 2002 WO
0232383 Apr 2002 WO
0232386 Apr 2002 WO
02055034 Jul 2002 WO
2004002411 Jan 2004 WO
2004019858 Mar 2004 WO
WO 2004054525 Jul 2004 WO
2005058258 Jun 2005 WO
2006011771 Feb 2006 WO
2006134051 Dec 2006 WO
2007003307 Jan 2007 WO
2007038733 Apr 2007 WO
2009024936 Feb 2009 WO
2010015517 Feb 2010 WO
2010023559 Mar 2010 WO
2010049434 May 2010 WO
2011134785 Nov 2011 WO
2011146282 Nov 2011 WO
2012033813 Mar 2012 WO
2012080321 Jun 2012 WO
2012084532 Jun 2012 WO
2012084876 Jun 2012 WO
2012164064 Dec 2012 WO
2013071182 May 2013 WO
2013092080 Jun 2013 WO
2013136480 Sep 2013 WO
2014016407 Jan 2014 WO
2014072490 May 2014 WO
2014118212 Aug 2014 WO
2014125452 Aug 2014 WO
2014144076 Sep 2014 WO
2014167508 Oct 2014 WO
2014207097 Dec 2014 WO
2015017768 Feb 2015 WO
2015026994 Feb 2015 WO
2015033351 Mar 2015 WO
2015058942 Apr 2015 WO
2015069823 May 2015 WO
2015075064 May 2015 WO
2015118357 Aug 2015 WO
2015133382 Sep 2015 WO
2015175986 Nov 2015 WO
2016005114 Jan 2016 WO
2016005144 Jan 2016 WO
2016058749 Apr 2016 WO
2016069877 May 2016 WO
2016091492 Jun 2016 WO
2016098870 Jun 2016 WO
2016100885 Jun 2016 WO
2016102543 Jun 2016 WO
2016120642 Aug 2016 WO
2016161360 Oct 2016 WO
2016179017 Nov 2016 WO
2015198203 Dec 2016 WO
2016207840 Dec 2016 WO
2017041903 Mar 2017 WO
2017041905 Mar 2017 WO
2017041906 Mar 2017 WO
2017041907 Mar 2017 WO
2017041908 Mar 2017 WO
2017041909 Mar 2017 WO
2017041910 Mar 2017 WO
2017059646 Apr 2017 WO
2017085117 May 2017 WO
2017091794 Jun 2017 WO
2017091796 Jun 2017 WO
2017091797 Jun 2017 WO
2017091800 Jun 2017 WO
2017102855 Jun 2017 WO
2017102936 Jun 2017 WO
2017116465 Jul 2017 WO
2017196299 Nov 2017 WO
2017207198 Dec 2017 WO
2018081399 May 2018 WO
2018085478 May 2018 WO
Non-Patent Literature Citations (238)
Entry
Translation of Notice of Reasons for Rejection for Application No. 2022-020688, dated Jan. 10, 2023.
Non-Final Office Action for copending U.S. Appl. No. 17/356,131, dated Jan. 19, 2023 (now abandoned).
Translation of Decision on Rejection for counterpart CN Application No. 201880034056.5, dated Jan. 9, 2023.
Translation of Chinese Second Office Action for counterpart Application No. 201880084390.1, dated Feb. 18, 2023.
Non-Final Office Action for copending U.S. Appl. No. 15/356,967, dated Dec. 30, 2022.
Third Party Submission for copending U.S. Appl. No. 17/694,821, dated Dec. 19, 2022.
Translation of Chinese Second Office Action for counterpart Application No. 201880021603.6, dated Dec. 8, 2021.
Non-Final Office Action for copending U.S. Appl. No. 15/339,035, dated Oct. 27, 2022.
Translation of Chinese Office Action for counterpart Application No. 2019800675489, dated Oct. 12, 2022.
Copending U.S. Appl. No. 15/484,625, filed Apr. 11, 2017.
Copending U.S. Appl. No. 15/484,663, filed Apr. 11, 2017.
Copending U.S. Appl. No. 15/339,035, filed Oct. 31, 2016.
PCT/US2016/03172 International Search Report and Written Opinion dated Sep. 19, 2016.
PCT/US2016/063724 International Search Report and Written Opinion dated Feb. 2, 2017.
PCT/US2016/063732 International Search Report and Written Opinion dated Feb. 6, 2017.
PCT/US2016/063728 International Search Report and Written Opinion dated Feb. 1, 2017.
Mintel: “Abundant Volume Conditioner,” Alterna Professional Haircare, Database Record No. 2177147, Sep. 2013.
Mintel: “Hair Colourant,” Catzy Hair Colourant, Database Record ID 743114, Jul. 2007, 4 pages.
Mintel: “Combing Cream,” Devintex Cosmeticos, Database Record No. 1595490, Jul. 2011.
Mintel: “Combing Cream,” Devintex Cosmeticos, Database Record No. 1595658, Jul. 2011.
Mintel: “Conditioner,” Devintex Cosmeticos, Database Record No. 1595545, Jul. 2011.
Mintel: “Conditioner,” Laperle Haircare, Database Record No. 3645337, Feb. 2016.
Mintel: “Conditioner,” Laperle Haircare, Database Record No. 3790215, Feb. 2016.
Mintel: “Conditioner,” Liqwd, Database Record No. 1172691, Sep. 2009.
Mintel: “Conditioner,” TIGI, Database Record No. 1442418, Nov. 2010.
Mintel: “Conditioner,” TIGI International, Database Record No. 1445427, Nov. 2010.
Mintel: “Conditioner,” TGI International, Database Record No. 3280151, Jul. 2015.
Mintel, “Masque for Beautiful Color,” Oribe Hair Care, Database Record No. 1522953, Mar. 2011.
Mintel: “Moisturizing Conditioner,” Frederic Fekkai, Datablase Record No. 1507159, Mar. 2011.
Mintel: “Post-Service Perfector,” Redken, Database Record No. 4326453, Nov. 2016.
Mintel: “Step 3—Conditioner,” L'OREAL, Database Record No. 4353779, Oct. 2016.
Mintel: “Step 3—Conditioner,” L'OREAL, Database Record No. 4609117, Feb. 2017.
International Preliminary Report on Patentability for PCT/US2016/30172, dated Jun. 19, 2017.
Non-Final Office Action for U.S. Appl. No. 15/484,625, dated Jun. 21, 2017.
Final Office Action for U.S. Appl. No. 15/484,625, dated Nov. 14, 2017.
Non-Final Office Action for U.S. Appl. No. 15/484,663, dated Jun. 21, 2017.
Final Office Action for U.S. Appl. No. 15/484,663, dated Nov. 28, 2017.
Non-Final Office Action for U.S. Appl. No. 15/339,035, dated Jan. 10, 2018.
International Search Report for PCT/US2017/058495, dated Jan. 5, 2018.
Third Party Submission for U.S. Appl. No. 15/484,663, filed Feb. 28, 2018 with attachments.
Pressly, Eric, et al., U.S. Appl. No. 61/994,709, filed May 16, 2014 and became publicly available on Nov. 19, 2015.
Estetica: the hairstyling professional magazine, (http://estetica.it/int/a/schwarzkopf-professional-launches-fibreplex), “Schwarzkopf Professional Launches Fibreplex,” published Sep. 23, 2015 reporting that Fibreplex® was launched during Sep. 2015.
Fibreplex® No. 1 Product Label.
Fibreplex® No. 1 Material Safety Data Sheet.
International Preliminary Report on Patentability for counterpart Application No. PCT/US2016/063727, dated Jun. 7, 2018.
International Preliminary Report on Patentability for counterpart Application No. PCT/US2016/063732, dated Jun. 7, 2018.
International Preliminary Report on Patentability for counterpart Application No. PCT/US2016/063728, dated Jun. 7, 2018.
Non-Final Office Action for copending U.S. Appl. No. 15/484,625, dated Jun. 20, 2018.
International Preliminary Report on Patentability for counterpart Application No. PCT/US2016/063724, dated Jun. 7, 2018.
Non-Final Office Action for copending U.S. Appl. No. 15/339,035, dated Oct. 5, 2018.
Notice of Allowance for copending U.S. Appl. No. 15/484,625, dated Oct. 31, 2018.
Bayraktar, V.N., “Organic Acids Concentration in Wine Stocks After Saccharomyces cerevisiae Fermentation,” Biotechnologia Acta, vol. 6, No. 2, Jan. 1, 2013, pp. 97-106.
Supplementary European Search Report for counterpart Application EP16789846, dated Oct. 30, 2018.
Communication Pursuant to Rules 70(32) and 70a(2) EPC for counterpart Application EP16789846, dated Jan. 23, 2019.
Written Opinion for counterpart Application EP16789846, dated Jan. 23, 2019.
Supplementary Extended Search Report and Written Opinion for counterpart European Application No. 16869324, dated Apr. 25, 2019.
Mintel: “Conditioner,” Unilever, XP055576888, Database accession No. 1419415, Oct. 21, 2010.
Mintel: “Conditioner,” Unilever, XP055576893, Database accession No. 3014885, Mar. 2, 2015.
Translation of Chinese Office Action for counterpart Application No. 201680079774.5, dated Sep. 1, 2020.
Fridman, R.A., “Technology of Cosmetics,” publ. of “Food Industry,” 1964, pp. 3-6, 297-308, 411-428 and 441-466.
Zefirova, N.S. “Big Russian Encyclopedia,” Chemical Encyclopedia, 1995, vol. 4, pp. 183-185.
Third Party Submission for U.S. Appl. No. 16/712,326, filed Sep. 8, 2020 with attachments.
Mexican Office Action for counterpart Application No. MX/a/2017/013983, dated Sep. 15, 2020.
Non-Final Office Action for copending U.S. Appl. No. 16/176,350, dated Sep. 30, 2020.
Non-Final Office Action for copending U.S. Appl. No. 15/778,807, dated Oct. 9, 2020.
Japanese Notice of Reasons for Refusal for counterpart Application No. 2019-553190, dated Oct. 27, 2020.
Translation of Korean Notice of Last Preliminary Rejection for counterpart Application No. 10-2018-7017668, dated Oct. 21, 2020.
Non-Final Office Action for copending U.S. Appl. No. 15/942,042, dated Nov. 12, 2020.
Final Office Action for copending U.S. Appl. No. 15/356,967, dated Nov. 17, 2020.
Final Office Action for copending U.S. Appl. No. 15/357,056, dated Nov. 19, 2020.
Japanese Office Action for counterpart Application No. 2018-546408, dated Dec. 7, 2020.
Japanese Notice of Reasons for Rejection for counterpart Application No. 2019-553559, dated Dec. 1, 2020.
Japanese Notice of Reasons for Rejection for counterpart Application No. 2019-564945, dated Dec. 1, 2020.
Final Office Action for copending U.S. Appl. No. 16/234,883, dated Dec. 24, 2020.
Translation of Third Party Observation for Application No. 2018-546408, dated Sep. 11, 2020.
European Office Action for counterpart Application No. 16869327.3-1112, dated Dec. 18, 2020.
Translation of Russian Office Action for counterpart Application No. 2018114758/04, dated Dec. 21, 2020.
Non-Final Office Action for copending Application No. 16/455, 139, dated Jan. 26, 2021.
Chinese Office Action for counterpart Application No. 201680039105.5, dated Feb. 4, 2021.
European Office Action for counterpart Application No. 16869330.7-1112, dated Feb. 4, 2021.
European Office Action for counterpart Application No. 16869324.0-1112, dated Feb. 18, 2021.
Translation of Chinese Office Action for counterpart Application No. 201680079800.4, dated Feb. 24, 2021.
Translation of Chinese Office Action for counterpart Application No. 201880021603.6, dated Mar. 2, 2021.
Final Office Action for copending U.S. Appl. No. 15/941,916, mailed Mar. 10, 2021.
Final Office Action for copending U.S. Appl. No. 15/941,965, mailed Apr. 5, 2021.
Supplemental Search Report for Chinese Application No. 201680079800.4, dated Feb. 18, 2021.
Partial Translation of Office Action for copending MX Application No. MX/a/2017/013983, dated Apr. 4, 2021.
Translation of Chinese Office Action for counterpart Application 201680079773, dated Apr. 14, 2021.
Chinese Office Action for counterpart Application No. 201680079110.9, dated Apr. 26, 2021.
Final Office Action for copending U.S. Appl. No. 15/942,042, dated May 12, 2021.
Translation of Japanese Office Action for counterpart Application No. 2017-557074, dated May 31, 2021.
Non-Final Office Action for copending U.S. Appl. No. 15/942,085, dated Jun. 8, 2021.
Tetrasodium Etidronate, https://uk.lush.com/ingredients/tetrasodium-etidronate. Published Mar. 28, 2020.
Shoup, F.K. et al., “Amino Acid Composition of Wheat Varieties and Flours Varying Widely in Bread-Making Potentialities,” Journal of Food Science, vol. 31, Issue 1, published Jan. 1966, pp. 94-101.
“Oxy Cream,” Makki Cosmetics, https://www.makkicosmetics.com/makki/showProductjsp?productID=Oxy25030&brandID=Makki, published: Jun. 30, 2016.
Non-Final Office Action for copending U.S. Appl. No. 15/339,035, dated Jun. 25, 2021.
Non-Final Office Action for copending U.S. Appl. No. 15/603,889, dated Jun. 25, 2021.
Japanese Notice of Reasons for Refusal for counterpart Application No. 2019-553190, dated Jun. 12, 2021.
Final Office Action for copending U.S. Appl. No. 15/778,807, dated Jul. 21, 2021.
Non-Final Office Action for copending U.S. Appl. No. 15/356,967, dated Jul. 22, 2021.
Translated Russian Office Action for counterpart Application No. 2018114758/04(023100), dated Jul. 20, 2021.
Chinese Office Action for counterpart Application No. 201680079110.9, dated Aug. 5, 2021.
Copending U.S. Appl. No. 17/228,040, Titled: “Compositions for Altering the Color of Hair,” Inventors: Kimberly Dreher et al., filed Apr. 12, 2021.
Copending U.S. Appl. No. 17/403,327, Titled: “Hair Treatment Compositions, Methods, and Kits for Treating Hair,” Inventors: Barbara Mitchell et al., filed Aug. 16, 2021.
Final Office Action for copending U.S. Appl. No. 16/455,139, dated Aug. 11, 2021.
Non-Final Office Action for copending U.S. Appl. No. 16/234,883, dated Sep. 17, 2021.
Final Office Action for copending U.S. Appl. No. 15/942,085, dated Sep. 21, 2021.
Chinese Office Action for counterpart Application No. 201880021603.6, dated Dec. 8, 2021.
Chinese Office Action for counterpart Application No. 201880034065.4, dated Dec. 22, 2021.
Final Office Action for copending U.S. Appl. No. 15/603,889, dated Jan. 6, 2022.
Translation of Chinese Office Action for counterpart Application No. 201680039105.5, dated Jan. 14, 2022.
Translation of Chinese Office Action for counterpart Application No. 201880034056.6, dated Dec. 28, 2021.
Translation of Japanese Notice of Reasons for Refusal for counterpart JP Application No. 2021-071866, dated Mar. 28, 2022.
Extended European Search Report for counterpart EP Application No. 21204522.3-1112, dated Mar. 30, 2022.
Final Office Action for copending U.S. Appl. No. 15/356,967, dated Mar. 31, 2022.
Final Office Action for copending U.S. Appl. No. 16/234,883, dated Apr. 12, 2022.
Final Office Action for copending U.S. Appl. No. 15/339,035, dated Apr. 14, 2022.
Japanese Notice of Opposition for Japanese Patent No. 6,930,994, dated Mar. 28, 2022 (no translation available).
Third Party Submission for counterpart Application No. EP 20160869327, dated Apr. 22, 2022.
Communication Pursuant to Rule 114(2) EPC (Third Party Observation) for EP Application No. 20160869324, dated Apr. 22, 2022.
U.S. Appl. No. 61/994,709 for “Hair Treatment Compositions and Methods,” Inventors: Eric D. Pressly and Craig J. Hawker, filed May 16, 2014.
“Practical Modern Hair Science,” Chapter 4, Edited by Trefor Evans and R. Randall Wickett, Allured Business Media, 2012, pp. 1065-1-1065-45.
Third Party Submission and Concise Description of Relevance for U.S. Application No. 17/356, 132, dated Apr. 20, 2022.
First Office Action for counterpart Chinese Application No. 201880084390.1, dated Jun. 30, 2022.
Third Party Submission for counterpart Application No. EP 20160869330, dated May 6, 2022.
Third Party Submission for copending U.S. Appl. No. 17/379,405, filed May 10, 2022.
Non-Final Office Action for copending U.S. Appl. No. 15/942,042, dated May 23, 2022.
Translation of Second Chinese Office Action for counterpart Application No. 201880034056.5, dated May 30, 2022.
European Office Action for counterpart Application No. 16789846.9-1109, dated Jul. 6, 2022, translation.
Third Party Submission and Concise Description of Relevance for copending U.S. Appl. No. 17/403,327, dated Jun. 27, 2022.
Korean Notice of Final Rejection for counterpart KR Application No. 10-2021-7019867, dated Jul. 22, 2022, translation.
Third Party Submission for copending U.S. Appl. No. 17/356,131, dated Apr. 20, 2022.
International Preliminary Report on Patentability for counterpart Application No. PCT/US2018/025418, dated Oct. 1, 2019.
Notice of Allowance for copending U.S. Appl. No. 15/604,152, dated Oct. 2, 2019 (now U.S. Pat. No. 10,561,599).
Non-Final Office Action for copending U.S. Appl. No. 15/604,152, dated Jun. 13, 2019.
Olaplex with relaxers, OLAPEX™, pp. 1-2, Apr. 11, 2017, https://olaplex.es/olaplex-with-relaxers/.
Relaxers, resource Library, Olaplex Education, pp. 1-2, Apr. 11, 2017, https://help.olaplex.com/detail/relaxers.
Notice of Allowability for copending U.S. Appl. No. 15/604,152, dated Dec. 10, 2019.
International Search Report and Written Opinion for counterpart Application No. PCT/US2018/034366, dated Jul. 25, 2018.
Anonymous: “Curly Hair Conditioner,” Mintel, GNPD, XP002742449, 2015, pp. 1-2.
Corrected Notice of Allowability for copending U.S. Appl. No. 15/604,189, dated Dec. 11, 2019 (now U.S. Pat. No. 10,576,307).
Notice of Allowance for copending U.S. Appl. No. 15/604,189, dated Oct. 22, 2019.
Non-Final Office Action for copending U.S. Appl. No. 15/604,189, dated Apr. 8, 2019.
International Search Report and Written Opinion for counterpart Application No. PCT/US2018/034371, dated Nov. 16, 2018.
Mintel: “Hydrating Hair Colour,” Garnier, Jan. 2017, pp. 1-6.
Mintel: “Masque Force Architecte Reconstructing Masque,” L'Oreal, Feb. 2012, pp. 1-6.
Final Office Action for copending U.S. Appl. No. 15/603,889, dated Jul. 12, 2019.
Non-Final Office Action for copending U.S. Appl. No. 15/603,889, dated Jan. 2, 2019.
International Search Report and Written Opinion for counterpart Application No. PCT/US2018/034378, dated Jul. 24, 2018.
Final Office Action for copending U.S. Appl. No. 16/234,883, dated Mar. 11, 2020.
Non-Final Office Action for copending U.S. Appl. No. 16/234,883, dated Sep. 16, 2019.
International Search Report and Written Opinion for counterpart Application No. PCT/US2018/067814, dated Feb. 25, 2019.
Final Office Action for copending U.S. Appl. No. 16/176,350, dated Apr. 8, 2020.
Non-Final Office Action for copending U.S. Appl. No. 16/176,350, dated Nov. 14, 2019.
International Search Report and Written Opinion for counterpart Application No. PCT/US2019/059002, dated Feb. 4, 2020.
Korean Notification of Reason for Refusal for counterpart Application No. KR10-2017-7034789, dated May 19, 2020 (translation).
Final Office Action for copending U.S. Appl. No. 15/942,042, dated Jun. 1, 2020.
JP Notice of Reasons for Refusal for Application No. 2017-557074, dated Jun. 1, 2020.
Non-Final Office Action for copending U.S. Appl. No. 15/942,085, dated Jun. 19, 2020.
Shiseido Super Mild Hair Care-Shampoo & Conditioner Refill Set. Https://web.archive.org/web/20160326190615/http://www.truenu.com/TR/Shiseido-Super-Mild-Hair-Care-Shampoo-Conditioner-Refill-Set-Two-400ml-Refill-Pouches-Details.html. Published Mar. 26, 2016.
Non-Final Office Action for copending U.S. Appl. No. 15/941,916, dated Jun. 24, 2020.
Non-Final Office Action for copending U.S. Appl. No. 15/941,965, dated Jul. 15, 2020.
Third Party Observation for counterpart Application No. EP20160869330, dated Jun. 26, 2020.
Translation of Japanese Office Action for counterpart Application No. 2018-526844, dated Aug. 3, 2020.
Translation of Chinese Office Action for counterpart Application No. 201680079110.9, dated Aug. 11, 2020.
Ruiming, Li, “Hairdressing Technology,” China Railway Publishing House, Jun. 30, 2015, pp. 112-113.
Translation of Mexican Office Action for counterpart Application No. MX/a/2018/005829, dated Jul. 13, 2020.
Non-Final Office Action for copending U.S. Appl. No. 16/234,883, dated Aug. 26, 2020.
Mascolo Group, label.m Anti-Frizz Mist, MINTEL GNPD, record ID5618119, published Apr. 2018, p. 1-5.
Federici Brands, Color WOW Dream Coat Supernatural Spray, MINTEL GNPD, record ID5637153, published Apr. 2018, p. 1-2.
Garnier, Garnier Fructis Sleek & Shine Moroccan Sleek Oil Treatment, MINTEL GNPD, record ID1876023, published Sep. 2012, p. 1-2.
Ouai, Leave-In Conditioner, Mintel Gnpd, record ID5781323, published Jun. 2018, p. 1-2.
Redken, Redken Pillow Proof Express Treatment Primer, MINTEL GNPD, record ID5117339, published Sep. 2017, p. 1-4.
Redken, Redken Pillow Proof Express Primer Time-Saving Blowdry Primer with Heat Protection, MINTEL GNPD, record ID6117357, published Nov. 2018, p. 1-2.
Redken, Redken Pillow Proof Time-Saving Blowdry Primer with Heat Protection, MINTEL GNPD, record ID4537755, published Jan. 2017, p. 1-3.
Copending U.S. Appl. No. 16/455,139, “Hair Treatment Compositions and Methods for Treating Hair,” filed Jun. 27, 2019.
Translation of Russian Office Action for counterpart Application No. 2017134681-04, dated Aug. 17, 2020.
Translation of Chinese Office Action for counterpart Application No. 201680079800.4, dated Aug. 24, 2020.
Search Report for counterpart Chinese Application No. 201680079800.4, dated Aug. 24, 2020.
Translation of Chinese Office Action for counterpart Application No. 201680079773.0, dated Aug. 21, 2020.
Search Report for counterpart Chinese Application No. 201680079773.0, dated Aug. 21, 2020.
Translation of Japanese Office Action for counterpart Application No. 2018-546409, dated Sep. 7, 2020.
1 Non-Final Office Action for copending U.S. Appl. No. 17/694,821, dated Apr. 14, 2023.
“Olaplex Alleges Patent Infringement by L'OREAL re Hairbond-Building Prior to Colouring,” Focus on Pigments, vol. 2017, No. 3, Mar. 31, 2017, p. 7.
Final Office Action for co-pending U.S. Appl. No. 15/339,035, dated May 2, 2019.
International Preliminary Report on Patentability for counterpart Application No. PCT/US2017/058495 dated May 9, 2019.
Notice of Allowance for copending U.S. Appl. No. 15/778,803, dated Jun. 3, 2019.
Extended European Search Report for counterpart Application No. 16869327.3-1114, dated Jun. 4, 2019.
Mintel: “Detox 7 Day Cure Purifying Serum,” XP055593471, Jeanne Gatineau, Feb. 11, 2013.
Extended European Search Report for counterpart Application No. 16869330.7-1114, dated Jul. 5, 2019.
Extended European Search Report for counterpart Application No. 16869326.5-1114 dated Jun. 26, 2019.
Translation of Mexican Office Action for counterpart Application No. MX/a/2018/005829, dated Jun. 13, 2019.
Non-Final Office Action for co-pending U.S. Appl. No. 15/339,035, dated Aug. 20, 2019.
Mexican Office Action for counterpart Application No. MX/a/2017/013983, dated Jul. 2, 2019.
Notice of Allowance for co-pending U.S. Appl. No. 16/042,478, dated Sep. 25, 2019.
Non-Final Office Action for co-pending U.S. Appl. No. 15/778,807, dated Sep. 30, 2019.
Brazilian Office Action for counterpart Application No. BR112017023380-0, dated Oct. 10, 2019.
Brazilian Office Action for counterpart Application No. BR112018010381-0, dated Nov. 25, 2019.
Brazilian Office Action for counterpart Application No. BR112018010357-8, dated Nov. 25, 2019.
Mexican Office Action for counterpart Application No. MX/a/2018/005829, dated Oct. 5, 2019.
Brazilian Office Action for counterpart Application No. BR112018010344, dated Nov. 25, 2019.
Mexican Office Action for counterpart Application No. MX/a/2017/013983, dated Dec. 16, 2019.
Japanese Office Action for counterpart Application No. 2018-526844, dated Dec. 23, 2019.
Japanese Office Action for counterpart Application No. 2018-546409, dated Dec. 23, 2019.
Brazilian Written Opinion for counterpart Application No. BR112018010341, dated Nov. 25, 2019.
Non-Final Office Action for counterpart Japanese Application No. 2018-546408, dated Jan. 6, 2020.
Mintel: “Tonic,” Dr. Kurt Wolff, Dr. Wolff Plantur 39, ID# 3133037, Apr. 2015.
Mintel: “Conditioner,” LG Household & Health Care, Beyond Professional, ID# 3240637, Jun. 2015.
Russian Office Action for counterpart Application No. 2018114758/04, dated Dec. 13, 2019.
Translated Notification of Reasons for Refusal for counterpart KR Application No. 10-2018-7017668, dated Jan. 21, 2020.
Translated Office Action for counterpart RU Application No. 2017134681/04(0060925), dated Dec. 30, 2019.
Non-Final Office Action for copending U.S. Appl. No. 15/778,805, dated Feb. 12, 2020.
Final Office Action for copending U.S. Appl. No. 15/778,807, dated Mar. 13, 2020.
Final Office Action for copending U.S. Appl. No. 15/339,035, dated Apr. 10, 2020.
Non-Final Office Action for copending U.S. Appl. No. 16/273,787, dated Apr. 9, 2020.
International Search Report and Written Opinion for counterpart Application No. PCT/US2017/059827, dated Jun. 28, 2018.
“LAMESOFT PO 65 Datasheet,” Retrieved from the internet on Jun. 7, 2018, http://e-applications.basf-ag.de/data/basf-pcan/pds2/pds2-web.nsf.
Non-Final Office Action for copending U.S. Appl. No. 15/356,967, dated May 3, 2017.
Final Office Action for copending U.S. Appl. No. 15/356,967, dated Dec. 4, 2017.
Non-Final Office Action for copending U.S. Appl. No. 15/356,967, dated Aug. 24, 2018.
Final Office Action for copending U.S. Appl. No. 15/356,967, dated Apr. 11, 2019.
Non-Final Office Action for copending U.S. Appl. No. 15/356,967, dated Feb. 21, 2020.
International Search Report and Written Opinion for counterpart Application No. PCT/US2017/059817, dated Feb. 6, 2018.
Non-Final Office Action for copending U.S. Appl. No. 15/357,056, dated Apr. 16, 2020.
Non-Final Office Action for copending U.S. Appl. No. 15/942,042, dated Jan. 24, 2020.
ALS “Cocamidopropyl betaine,” printed 2020; http://www.caslab.com/Cocamidopropyl_betaine_CAS_61789-40-0.
International Search Report and Written Opinion for counterpart Application No. PCT/US2018/025466, dated Jul. 9, 2018.
International Preliminary Report on Patentability for counterpart Application No. PCT/US2018/025466, dated Oct. 1, 2019.
International Search Report and Written Opinion for counterpart Application No. PCT/US2018/025448, dated Jul. 9, 2018.
International Preliminary Report on Patentability for counterpart Application No. PCT/US2018/025448, dated Oct. 1, 2019.
International Search Report and Written Opinion for counterpart Application No. PCT/US2018/025431, dated Jun. 20, 2018.
International Preliminary Report on Patentability for counterpart Application No. PCT/US2018/025431, dated Oct. 1, 2019.
Translation of Brazilian Office Action for counterpart Application No. BR112021006046-4, dated May 2, 2023.
Translation of Chinese Office Action for counterpart Application No. CN202110948497.X, dated Apr. 26, 2023.
Non-Final Office Action for copending U.S. Appl. No. 17/531,407, dated Jul. 6, 2023.
Final Office Action for copending U.S. Appl. No. 15/941,965, mailed Jul. 3, 2023.
“Bigen Speedy Hair Color Conditioner-Natural Black 881,” Aug. 5, 2013, https://www.cosdna.com/chs/cosmetic-8836116377.html.
Second Chinese Office Action for counterpart Application No. 201980067548.9, dated Jul. 12, 2023 (translation unavailable).
Related Publications (1)
Number Date Country
20210369591 A1 Dec 2021 US
Continuations (1)
Number Date Country
Parent 16176350 Oct 2018 US
Child 17403327 US